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Aim: To determine the health-related quality of life (HRQoL) in Macassar residents with 
persistent lower respiratory symptoms and/or asthma (PLRS and/or asthma), six years after a 
sulphur stockpile fire disaster. 
Methods: A cross-sectional analysis of responses from affected residents was conducted six 
years after the incident. Information was obtained from a dataset of 4000 respondents to an 
interviewer-administered questionnaire that included medical history, respiratory symptoms 
and HRQOL using the Medical Outcomes Study Form 36 (SF-36). The respondents surveyed 
six years after the fire, provided information for three different time points, prior to, one year 
and six years after the fire. 
Results: A total of 246 records of residents, 74 with PLRS/asthma and 172 without 
PLRS/asthma were analysed. The mean age of the symptomatic group was 49 (SD:12) years 
and 47 (SD:13) years in those without symptoms. Approximately 60% of the residents were 
current and ex-smokers in both groups. A greater proportion were women (61.3%) and 68% 
of women reported PLRS/asthma. The mean SF-36 scores were significantly lower for the 
symptomatic group in the Physical Functioning (24 vs. 39), Role Physical (33 vs. 48) and 
General Health domain (24 vs. 37). Residents with PLRS/asthma, were more likely to 
experience a significant decline in their Role Physical (OR=1,97; CI 1,09-3,55) and General 
Health (OR=7,07; CI 2,88-17,35) at year 1 and General Health (OR=3,50; CI 1,39-8,79) at 











upper airways dysfunction syndrome) demonstrated even stronger associations for General 
Health (OR=7,04; CI 1,61-30,7) at year 1 and at year 6 (OR=8.58; CI 1,10-65,02).  
Conclusion: This study highlights the long-term adverse impact on HRQOL among residents 
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HEALTH - RELATED QUALITY OF LIFE AMONGST MACASSAR 
RESIDENTS WITH PERSISTENT LOWER RESPIRATORY 
SYMPTOMS AND/OR ASTHMA FOLLOWING A SULPHUR 




During the anti-apartheid trade sanction era, the South African government found it necessary 
to stockpile sulphur for the manufacture of sulphuric acid and fertilizers. A chemical company 
acting as an agent for the government stored the sulphur at its large Somerset West factory in 
the Western Cape Province. The storing of sulphur started in the late 1960s when the 
surrounding area was largely unpopulated and underdeveloped.1 However, the geographic and 
demographic composition of the area had changed dramatically into a developed area 
occupied by approximately  30,000 – 40, 000 people at the time of the disaster. On the 16-17 
December 1995, 15 000 tons of sulphur ignited, resulting in exposure of high levels of sulphur 
dioxide (SO2) vapours amongst  the Macassar residents and the surrounding residential and 
farming areas.2 
 
Based on the plume-model concentration of SO2 levels, the level of SO2 ranged from 20 – 
200ppm in Macassar.2 Baterman et al. estimated that the inhabitants were exposed to high 
concentrations of smoke and sulphur dioxide, with the main route of exposure being via 
inhalation of the gaseous SO2.
3 This kind of chemical disaster, namely the burning of a 
sulphur stockpile, had not been previously reported. The Macassar disaster was the first of its 
kind. Approximately 3 000 people had to be evacuated to ‘safe areas’ and many residents 











amongst the Macassar residents reported shortly after the catastrophe included coughing 
(74%), burning eyes (71%), burning nose and throat (67%), burning chest (62%), anxiety and 
fear (40%), cramps (36%), and vomiting (21%). However, the symptoms one week after the 
fire were mainly confined to the chest, nose and throat region (90%). The official death toll as 
a direct result of the fire was reported to be between 10 – 15, but the precise number of deaths 
remained largely disputed.3 
 
The Desai Commission of inquiry was appointed to investigate the circumstances surrounding 
the Macassar disaster. The Commission concluded that the disaster occurred as a result of 
negligence on the part of the chemical company. Hence, the Macassar disaster project clinic 
was established. Many of the residents presented to the clinic for medical assessment and 
evaluation. The information gathered during this process formed the basis of various different 
investigations, including this study.  
 
Baatjies study, which assessed “the environmental and host factors associated with persistent 
lower respiratory symptoms among residents of Macassar six years after being acutely 
exposed to elevated exposures of SO2 vapours”, was one such study arising from the data 
collected by the Macassar disaster project clinic.4 This current study builds on the study by 
Baatjies and aims to determine the impact of persistent lower respiratory symptoms and 












2. Literature Review 
 
2.1. Introduction 
Quality Of Life (QOL) scale was originally created by American psychologist John Flanagan 
in the 1970’s.  QoL refers to an individual’s psychological, social and physical wellbeing and 
how this limits their ability to function in their daily activities. 5 The application of QoL in 
health care practice and research became steadily important and relevant as our understanding 
of what optimal health and well-being meant, changed. Thus, health no longer could be 
defined as mere absence of disease but also the presence of physical, mental, and social 
wellbeing. 6 
 
The inclusion of QoL in health care practice and research has given rise to the field of 
research called Health - Related Quality Of Life (HRQoL). HRQoL refers to, ‘the physical, 
psychological, and social domains of health, seen as distinct areas that are influenced by a 
person’s experiences, beliefs, expectations, and perceptions’. 7 HRQoL research, therefore 
enables health care practitioners and researchers to assess the impact of different diseases and 
treatment in a comprehensive manner, by integrating objective functioning and patients’ 
subjective wellbeing. Thus, any two individuals with the same disease process may have very 
different qualities of life, as their expectations of health, and their ability to cope with the 
limitations and disability will affect their perceptions of health. 7-9 
  
2.2. Measuring HRQoL: The SF–36 questionnaire 
The Medical Outcomes Study (SF–36) questionnaire is a generic measure as opposed to 











measure can be used in general or specific populations, in order to assess the impact of a 
range of different diseases or treatment regimes. One of the main features of a generic 
measure is that it allows for the assessment of many dimensions of health in a comprehensive 
manner. Furthermore, generic measures can be useful in comparing the findings of different 
diseases or conditions. 10 SF-36 has been in use since 1990’s and is one of the most widely 
used generic health status measure currently. The SF-36 has been extensively validated in 
terms of internal consistency and its reliability has been tested among both diseased and 
general population groups. 11-15 SF-36 is commonly used in studies, in which the primary 
outcome is HRQoL. 
 
 The SF -36 incorporates eight health concepts (Table 1). These eight scales Physical 
Functioning (PF), Role – Physical (RP) and Bodily Pain (BP) Role – Emotional (RE), Mental 
Health (MH), Vitality (VT), and General Health (GH), Social Functioning (SF), are most 
widely used in health surveys and are highly affected by disease and treatment.11 The scores 
from all the eight scales range from 0 to 100. Scores of the items for the same scales can be 
aggregated without the need for standardization or item weighting. A high score is consistent 
with a positive health status. 11 The eight health domains can be further aggregated into two 
Summary Measures (SM) Physical Component Summary (PCS) and Mental Component 
Summary (MCS), in order to reduce the number of statistical comparisons, without losing 
vital information. The following three scales: Physical Functioning, Role – Physical and 
Bodily Pain correlates highly with physical component and thus  contributes largely to the 
PCS, whereas, Mental Health, Role –Emotional, and Social functioning  scales, correlate 
highly with mental component and contribute to the MCS. The following scales Vitality and 





























2.3. Measuring the HRQoL in asthma  
The relationship between impaired psychological, physical and emotional wellbeing amongst 
asthma sufferers has been well documented. 18 Symptoms of asthma such as shortness of 
breath, cough, chest tightness and wheeziness can restrict work and leisure activities, cause 
sleep disruptions and may result in high levels of anxiety and depression. 19, 20 HRQoL is only 
moderately associated with the traditional outcome measures, such as the forced expiratory 
volume in one second (FEV1), bronchial hyper-responsiveness, and medication use. This 
suggests, that these traditional measures do not adequately capture some important 
Scale                                            Number of                            Definition 
                                                       items 
 
1. Physical functioning                      10                  Extent to which health interferes with a variety  
                                                                                 of activities, such as sports, carrying groceries                   
,                                                                                climbing stairs, walking, bathing, dressing 
 
2.  Role limitations attributed             4                   Extent to which health interferes with usual daily 
      to physical problems                                          activities, such as work, housework, or school 
 
3.  Bodily pain                                    2                    Amount of pain and the extent to which bodily pain 
                                                                                  interferes with both work outside the home and 
                                                                                  housework 
 
4.  General health                               5                    Overall rating of current health in general 
  
5.  Vitality                                          2                    Extent of which one has energy or feeling of tiredness 
 
6.  Social functioning                         2                    Extent to which health interferes with normal social  
                                                                                  activities, such as visiting with friends during past 
                                                                                  month 
 
7. Role limitations attributed             3                    Extent to which health interferes with usual daily  
     to emotional problems                                        social activities for example, accomplished less than  
                                                                                 would like to 
 
8. Mental health                                 5                    General mood affect, including depression, anxiety,  




Table 1.  Illustrates the classification of items, scales and definition of the items of the SF-36 











dimensions of individuals suffering from asthma, which can have a major influence on 
HRQoL, these include patient’s life experiences, socio-economic status, emotional status, 
health beliefs, perception of symptoms, and expectations of health. 21, 22  Hence, clinicians and 
researchers require these subjective elements, in order to assess the true impact of asthma on 
the daily lives of asthma sufferers. Thus, in patients who have a chronic disease such as 
asthma, measuring the HRQoL, in addition to the traditional measures, provides a more 
meaningful way to determine the impact of health care, given that asthma can place a severe 
burden on emotional, physical and social aspects of an individual’s life. The main objective of 
health care therefore, is to ensure that patients experience a satisfactory quality of life. This 
has lead to a growing preoccupation amongst asthma researchers to measure the impact of 
asthma on HRQL and since the 1990’s there has been a steady increase in availability of 
literature, in which HRQL is one of the main outcomes . 
 
Studies have consistently shown that asthma diminishes both physical and mental health of 
asthmatics compared to non-asthmatics, in different study populations, irrespective of the 
scales, study design, and instruments used. 17, 18, 23-30 In a population-based study, current 
asthmatics were found to have lower HRQoL scores compared to ex- asthmatics or those who 
never had asthma. Asthmatics on average, experienced 10 days each month of impaired 
physical or mental health, which was almost, double the amount of days for non-asthmatics. 23  
 
2.4. The determinants of HRQoL among people with asthma 
2.4.1. Sex/gender  
Several epidemiological studies have demonstrated a relationship between sex/gender and 
HRQoL, in which female asthmatic patients report a poorer HRQL and symptoms compared 











reasons for these observed sex/gender differences. Wijnhoven et al highlighted some 
interesting findings regarding these sex/gender differences. They argue that the gender 
differences cannot be accounted for by differences in ‘objective disease severity’, since 
women had generally higher pulmonary function levels than men, but the differences are 
likely to be explained by ‘subjective disease parameters’. Women reported more severe 
dyspnoea, and a higher use of medication compared to men in their study. Given that 
dyspnoea is one of the main symptoms of anxiety disorders, and asthmatic women experience 
far greater psychological disorders, such as mood and anxiety disorders, compared to men, 
suggests that women may have more severe asthma in terms of subjective disease 
parameters.28 Belloch et al found that dyspnoea was the best predictor of HRQoL in asthmatic 
women, and this they argue may be related to, the higher anxiety and depression scores in 
women compared to men. Belloch et al further argue that the contribution of emotional 
disorders on HRQoL in asthmatic women is further compounded by age. Hence, as women 
aged, they experience more emotional disorders, thereby further diminishing their HRQoL 
compared to men. 29 
 
2.4.2. Age 
Studies have shown that age is a contributory factor on HRQoL in asthmatics, but the 
evidence is inconsistent. Some studies have shown that increasing age results in a decline in 
HRQoL amongst asthmatics, other studies have found poorer HRQoL scores amongst 
younger asthmatic patients compared to older asthmatics. Juniper et al found in their study 
that younger asthmatic patients had significantly diminished HRQoL compared to the older 
group. This they argue may be due greater adaptation to the limitations caused by asthma 
amongst the elderly. Thus, elderly asthmatics are less likely to be distressed by their asthma 











in a population based study found that young adults rated poorer HRQoL scores in terms of 
their physical health compared to elderly patients. 31 In contrast, other studies have shown 
poorer HRQoL scores as age increases in asthmatics. It is argued that among the elderly, co-
morbidity may well account for the association between age and poorer HRQoL.29, 32 
 
2.4.3 Asthma treatment 
Studies that have looked at the impact of treatment guideline (1997 National Institute of 
Health International asthma guideline) on HRQoL have found significant improvements in the 
HRQoL amongst asthmatics. A combined treatment of Inhaled corticosteroid with 
budesonide, fluticasone, and becclomethasone was found to improve HRQol 
amongstasthmatics.33, 34 Treatment with Beta- antagonists was also found to improve 
HRQoL.35, 36 In general, asthma patients treated according to guideline treatment, have been 
found to have far superior HRQoL scores, compared to patients not treated according to the 
treatment guidelines.37 
 
However, a recent study found that despite improvements in the overall HRQoL of asthma 
patients on guideline treatment, the psychological well-being of these patients remained 
significantly diminished due to high levels of anxiety and depression amongst asthmatics.38 
 
2.4.4. Smoking status 
There appears to be a significant association between smoking status and HRQoL in 
individuals with asthma. Current smokers experience a far greater decline in their HRQoL 
compared to non- smokers or former smokers.39, 40 However, it is still unclear, the mechanism 











smoking increases respiratory symptoms, which is found to impair HRQoL amongst 
asthmatics. 40 
 
2.4.5. Socioeconomic status 
Apter et al, found a strong association between individual level SES (education level, 
household income, occupational status and type of health insurance) and HRQoL. The study 
demonstrated that individuals with lower education, who were unemployed and had lower 
household income, had poorer asthma control, which contributed significantly to impaired 
HRQoL in both the AQLQ and Physical Component Summary (PCS) of the SF-36.41  
However, the sample size was relatively small (n=50) and therefore raises questions about the 
validity of the findings. Further studies are required in order to determine the relationship 
between socioeconomic status and HRQoL amongst asthmatics. 
 
2.2.6. Asthma with co-morbidity 
Very few studies have examined the impact of co-morbidity on HRQoL amongst asthmatics 
in any detail. Wijnhoven et al is one of few studies, which examines in detail, the impact of 
co-morbidity on HRQoL in asthmatic patients, using both the generic and the disease- specific 
questionnaire. The findings suggest that co-morbidity is an important determinant in both 
disease-specific and generic HRQoL among asthmatics. Most notably, the presence of more 
than one co-morbidity decreases the HRQoL in asthmatics significantly. In addition, the study 
demonstrated that asthmatics with cardiac history and hypertension had poorer disease-
specific HRQoL scores compared to generic HRQoL scores. Asthmatics with musculoskeletal 
disorders had the poorest generic HRQoL scores. The impact of diabetes and other chronic 













One of the limitations of Wijnhoven et al’s study is that it may have underestimated, the 
association between co-morbidity and HRQoL in asthmatics, given that the  sample was 
selected from general practice, where they are likely to have a  relatively mild form of the 
disease as opposed to outpatients clinics or hospitals, where patients are likely to suffer from 
more severe form of the diseases.24 Furthermore, Wijnhoven et al, did not examine the 
contribution of psychological disorders in asthmatics. Asthmatic patients are known to report 
higher rates of anxiety and depression compared to the general population.18 Moreover, 
studies have shown the adverse effect of depression and anxiety on HRQoL in 
asthmatics.25,28,29 Depression is found to profoundly impact on both physical and mental 
health domains in asthmatics. Asthmatics with more depressive symptoms rate significantly 
lower HRQoL compared to asthmatics with less depressive symptoms.42 
 
Nevertheless, despite its limitations, Wijnhoven et al’s study highlights some important 
considerations for asthma studies measuring HRQoL outcomes. Firstly, the importance of 
including co-morbidity in studies on HRQoL. Secondly, the importance of using both the 
asthma- specific and generic questionnaires in combination, as this will serve to strengthen 
the study and its findings. 
 
2.5. The impact of other chronic diseases on HRQoL 
Intervention of modern medicine has resulted in an increasing ageing population suffering 
from chronic diseases, which may adversely affect their HRQoL. Studies have shown the 
adverse impact of co-morbidity on HRQoL amongst those suffering from chronic diseases, 











which, an individual with asthma may rate their HRQoL and hence, distort the true 
relationship between asthma and HRQoL.  
 
2.5.1. Hypertension and HRQoL 
Despite the availability of literature, which attempts to describe the relationship between 
hypertension and HRQoL, it is still unclear whether hypertension is associated with HRQoL. 
Some studies have shown the adverse affect of hypertension on HRQoL, whereas other 
studies have shown no associations between hypertension and HRQoL.  
 
A recent study in a Chinese general population, Wang et al, found that hypertensive people 
had lower HRQoL compared to normotensives. Hypertensive patients were most affected by 
physical health and least affected by the mental health dimension. Furthermore, hypertensive 
patients with co-morbidity had lower HRQoL scores compared to hypertensive patients 
without co-morbidity. 43 Previous studies in western populations, have shown similar 
findings.44-46 Wagner and Strogatz, however found in their study, that individuals diagnosed 
with hypertension, had a lower HRQoL scores  compared to those who where hypertensive, 
but were unaware of their diagnosis. Thus, concluding that labelling patients with 
hypertension and/or the treatment highly influenced their rating of HRQoL as opposed to the 
disease itself. 47 These findings are consistent with other studies. 48, 49 
 
2.5.2. Diabetes mellitus and HRQoL 
Studies which have focused on HRQoL amongst diabetics in western populations have shown 
the adverse effects of diabetes on HRQoL .50-53 Diabetes mellitus was found to significantly 
diminish a patient’s physical health and functional health. In addition, the presence of co-











diabetics. Surprisingly, diabetics were not found to be negatively affected, in terms of their 
mental health compared to non-diabetic patients.50 In contrast, a recent study amongst 
Chinese patients in a primary care setting, showed a positive impact on HRQoL amongst 
diabetics compared to non–diabetics.  The authors argue that this discrepancy may lie in the 
different cultural adaptation to diseases between Western and Chinese populations, given that 
Chinese culture stresses the importance of endurance and acceptance to one’s fate. The 
authors go on to stress that further research is needed in this area to confirm their findings. 54 
 
2.5.3. Cardiac diseases and HRQoL 
Studies have shown that cardiovascular conditions adversely affect HRQoL in both physical 
health and mental health domains. 55-57 A recent study found that patients with congestive 
heart failure experienced a far greater decline in their HRQoL compared to other serious 
common chronic diseases and other cardiac conditions. 55, 56 Acute Myocardial Infarction and 
angina were also found to severely impair HRQoL. Furthermore, cardiac patients with co-
morbidity such as respiratory diseases, anxiety and depression rated significantly lower 
HRQoL compared to cardiac patients without co-morbidity .57 
 
2.5.4. Psychological disorders and HRQoL 
Studies have found that psychological disorders profoundly affect HRQoL. More importantly, 
these studies have shown, not only the impact of major depression on HRQoL, but also the 
significant contribution of  mixed depression and anxiety disorder  and  “subthreshold” 
disorders (patients who exhibit symptoms of depression and anxiety but the symptoms are not 
severe enough to warrant a diagnosis of anxiety and depression) on HRQoL. 58-60 Creed et al, 
found that both cases (with anxiety and/or depression) and subthreshold cases rated 











also on variables such as pain, physical limitation, and role functioning. Thus, highlighting the 
negative effect of psychological disorders on motivation for daily activities and perception of 
pain.58 Moreover, co-morbidity with psychological disorders, had an additive effect on 
HRQoL, so, for example the combined effect of coronary artery disease and depressive 
symptoms resulted in double the reduction in social functioning, compared to either condition 
on its own. 59, 60 
 
2.5.5. Musculo-skeletal disorders on HRQoL 
Muscular –skeletal conditions such as osteoarthritis or rheumatoid arthritis and chronic back 
pain has been found to greatly diminish HRQoL, in terms of both physical and mental 
health.61,62 Furthermore, muscular-skeletal disorders have been found to have a much greater 
impact on HRQoL than potentially life-threatening conditions such as cardiac disorders. 62 
 
In summary, research of this kind has not been carried out in South Africa. This study is 
carried out at patient level and not at a community level. It is hoped that the findings of this 
study will pave the way for further research in this area.  
 
Definition of persistent lower respiratory symptoms (PLRS) 
Persistent lower respiratory symptoms included wheeze, tight chest, irritant induced asthma, 
asthma aggravation and COPD, present at year 1 and 6 year after exposure.  
 
HRQoL scores 
Health related quality of life – 8 scales Physical Functioning (PF), Role Physical (RF) Bodily 
Pain (BP), General Health (GH), Vitality (V), Social Functioning (SF), Role Emotional (RE) 














To determine the degree of HRQoL impairment in residents with and without persistent lower 





 To describe the demographic characteristics of residents with or without persistent 
lower respiratory symptoms (PLRS) and/or asthma as a result of exposure to sulphur 
containing vapours associated with fire 
 
 To determine the HRQoL scores (PF, RP, BP, GH, V, SF, RE and MH) among 
residents with or without PLRS and/or asthma at 6 years after the fire. 
 
 To determine whether there is a difference in HRQoL scores between residents with or 
without PLRS and/or asthma. 
 
 To determine the proportion of residents with or without PLRS and/or asthma, who 
experienced impairment in their HRQoL scores, as measured by a decline in HRQoL 












 To determine whether the impaired  HRQoL scores, as measured by a decline in 
HRQoL scores, over 1 year and 6 years are related to age, gender, smoking status, 




The purpose of the study is to examine the impact of the fire on HRQoL amongst the residents 




6.1. Study Design 
A cross-sectional descriptive study design. 
 
6.2. Study population 
The study population consists of 4000 residents of Maccassar who presented themselves to 
the Macassar disaster project clinic for medical evaluation due to acute health effects (mainly 
upper and lower respiratory symptoms) as a result of acute exposure to SO2 vapours at the 
time of the fire. Within this group, there were a proportion of residents who experienced 
persistent lower respiratory symptoms and/or asthma 6 years after having been exposed to 
SO2 vapours. 
 
6.3. Sample size and procedure: 
The sample in this study will be selected from a case – control study conducted by Baatjiies.4 











and/or asthma). The inclusion criteria in this current study for diseased and non-diseased will 
be as follows: 
 
 
Diseased group (PLRS and/or asthma) 
Will consist of all the residents from Macassar who attended the clinic with persistent lower 
respiratory symptoms as a result of exposure to SO2 vapours. 
a) Residents of the Macassar area during the fire disaster (16 / 17 December 1995) and 
exposed to SO2 as a result thereof. 
b) Eighteen years or older at the time of exposure. 
c) Presented themselves to the Macassar disaster project clinic for medical evaluation. 
d) Must have had persistent (at year 1 and 6 years after the fire) respiratory symptoms 
and/ or asthma which in the opinion of the medical panel (MRP) was as a result of SO2 
vapours arising from the fire. 
e) Absence of any chronic respiratory disease, including active pulmonary tuberculosis at 
least one year prior to and two after the disaster, and at five to 7 years after the fire. 
 
Non-diseased group (No PLRS and/or asthma) 
Will consist of a random sample of residents who did not develop lower respiratory symptoms 
and/or asthma despite exposure to SO2 vapours. Similar to criteria a-c but free of persistent 
lower respiratory symptoms, asthma and other chronic respiratory illnesses such as TB at least 
one year prior to and two  years after the disaster,  and at five to 7 years after the fire. 
 
The selection of diseased and non-diseased will be in accordance with the predetermined 











disaster project clinic. A database of all attendees will be maintained. A proportion of the 
diseased residents will be selected and a random sample of non-diseased will be selected. 
 
6.4 Data collection 
Data collection will involve gathering information on the following parameters: 
 Demographics 
 Psychological Characteristics 
 Medical history 
 Presence or absence of lower respiratory symptoms due to the fire (health outcomes) 
 Health related quality of life scores 
 
Macassar –AECI fire disaster medical claimant’s project, screening questionnaire – 2001: 
(Appendix 1) 
The questionnaire was developed using background knowledge on symptoms suffered due to 
SO2 exposure from the literature. In order to refine the questionnaire and to determine the 
time it would take to complete the questionnaire pre-testing will be done on the questionnaire. 
The questionnaire was compiled as a structured interviewer–administered questionnaire, 
which mainly consists of close – ended questions in order to limit interpretation bias.  
 
To ensure reliability and validity the questionnaire will be translated into Afrikaans and then 
translated back into English. Furthermore, recording of observations and answers will be done 
in a systematic and accurate manner to ensure further reliability. A trained occupational health 
nurse with experience in data collection will conduct all interviews thus excluding interviewer 
variation, which may affect the reliability of the data collection process. A study such as this 











life over the past six years. In order to minimise re-call bias the interviewees will be unaware 
of the hypothesis of the study and therefore are unlikely to answer questions according to the 
expected outcome. 
 
Health – related quality of life assessment questionnaire (SF – 36): (Appendix 2) 
The reason why SF -36 questionnaire will be used (given that it is a generic measure)for this 
study as opposed to an asthma specific questionnaire (disease specific) is because the 
residents who presented themselves to the Macassar disaster project clinic for a medical 
assessment  and evaluation presented with various different diseases and medical  conditions. 
As indicated previously, a generic questionnaire allows one to assess a range of diseases or 
conditions. Furthermore, a generic measure allows one to measure many health related 
dimensions and thus removes the need to select specific dimensions for any particular disease 
or medical condition. Therefore, the SF-36 is considered to be the most appropriate 
assessment tool, as it allows one to measure the impact of different diseases or medical 
conditions on HRQL, given the limited time and resources 
 
The reliability, validity and responsiveness of the SF-36 has been widely reported in 
asthma.17, 63-65 In addition the SF-36 has been used in many HRQL studies amongst asthma 
patients.25, 28, 31, 41, 42, 66 Moreover, given that the SF-36 is the most widely used generic 
measure, the interpretation of the low and high scores are also well documented which allows 
for various different strategies to be implemented for the interpretation of results in a 












6.5 Ethical considerations 
All information collected on clients during the course of the study will be kept under the 
strictest confidence, in order to preserve the client’s privacy. Furthermore, the rights and 
welfare of the clients or their next-of-kin will be safeguarded by ensuring that a thorough 
explanation of the process of obtaining information and collection of data is provided. 69 In 
addition clients will be able to ask questions or discuss issues of importance during oral 
presentations to ensure the clients right to full disclosure. Written informed consent will be 
obtained only after it is clear that the client or the next-of-kin fully understood the purpose of 
the study. Unfortunately, the study cannot secure anonymity by replacing names of the clients 
with numbers as some of the clients may need to be referred for further medical evaluation, 
thus only confidentially can be guaranteed and not anonymity. All records will be kept in a 
locked cabinet for security reasons. Any agreement made between the researcher and the 
clients will be outlined and be honoured, particularly those relating to information on the 
outcome of the clients medical condition will be given in written form. All clients referred to 
specialist will be informed in writing concerning their diagnosis and treatment 
recommendations. All clients will be referred for legal assistance to assist with filing claims 
for compensation. (Appendices 3 & 4) 
 
7. Data Management and Analysis  
 
The following information on patient’s characteristics will be obtained; age (years), age at the 
onset of asthma, sex/gender, cigarette-smoking habits (never, former, current), PLRS and/or 
asthma, reactive upper airways dysfunction (RUDS), treatment of asthma and finally, chronic 
disease: hypertension, diabetes, musculo-skeletal disorders, cardiac history and psychological 











distort the relationship between asthma and HRQL, and therefore will be treated as potential 














Health related quality of life – 8 scales Physical Functioning (PF), Role Physical (RF) Bodily 
Pain (BP), General Health (GH), Vitality (V), Social Functioning (SF), Role Emotional (RE) 
and Mental Health (MH).  
 
Independent Variables 
1) Sex/gender   (Female =1 vs. Male =2) 
2) Age (Years)  
3) Depression (depression = 1 vs. no depression = 2) 
4) Anxiety (anxiety = 1 vs. no anxiety = 2) 
5) Smoking (never = 1, ex-smoker = 2, current smoker = 3) 
6) PLRS/ Asthma (PLRS/asthma =1 vs. no PLRS/asthma = 2) 
7) RUDS (RUDS = 1 vs. no RUDS = 2) 
8) Hypertension (hypertension = 1 vs. no hypertension = 2) 
8) Diabetes (diabetes = 1 vs. diabetes = 2) 
9) Cardiac disease (cardiac dx = 1 vs. no cardiac dx = 2) 
10) Musculo-skeletal (MS =1 vs. no MS =2) 
11) Treatment for asthma (no = 1 vs. high = 2) 
 
7.1. Data Analysis:  
The relationship between and HRQoL scores for the three periods 
  Shapiro–Wilk test was conduct in order to assess if the scores for the eight health 
profiles PF, RP, BP, GH, V, SF, RE, and MH were normally distributed, for the three 











 Friedman’s test (non-parametric test for more than 2 dependent samples) was 
conducted, to test the differences in the overall mean scores for the eight SF-36 scales. 
 
The relationship between diseased/non-diseased and HRQoL scores for the three periods 
 Conduct Shapiro-wilk test to test for normality for the diseased and non-diseased 
group. 
 Conduct appropriate test in order to test for the differences in scores for the eight SF-
36 scales and between the diseased and the non-diseased. 
 
 The independent variables and diseased/non-diseased, for the three time periods 
 Stratified the total population according to diseased vs. non-diseased for the 3 different 
time points. 
 Conduct Chi-square Test of Homogeneity between all the independent risk factors and 
diseased/non-diseased. 













Table 1. Total population, stratified according to diseased vs non-diseased, prior to fire, at 1 year and 6 years after       
        the fire  
 Diseased (n =72) Non-diseased (n = 174) 
 
 Prior      1 year     6 years    Prior          
 






18 – 49 years 
50 – 80 years 
 
 









      
Level of exposure 
Low 
High 
      
Treatment for asthma 
Yes 
      
RUDS       
Anxiety       
Depression       
Diabetes       
Cardiac hx       
Hypertension       
Muscular-skeletal        
 
 
Linear Regression Analysis to determine the relationship between diseased/non-diseased 
and HRQoL 
In order to determine the relationship between diseased/non-diseased and HRQoL, one would 
need to control for the following confounders: Age, sex/gender, depression, anxiety, smoking 
status, cardiac HX, hypertension, diabetes, muscular- skeletal disorders and treatment for 
asthma.  
 Conduct simple linear regression analysis between all the independent variable and the 
PF, RP, BP, GH, V, SF, RE, and MH subscales scores, for the 3 time periods; this will 












 Conduct multivariate linear regression analysis with PF, RP, BP, GH, V, SF, RE, and 
MH health profiles, and the independent variables, for the 3 time periods. This will 
determine the relationship between diseased/non-diseased and HRQoL, as the 
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HEALTH-RELATED QUALITY OF LIFE IN ASTHMA:  A REVIEW 
 
Asthma is a chronic disease, which is known to impair psychological, physical and emotional 
well-being. 1 Symptoms of asthma such as shortness of breath, cough, chest tightness and 
wheeziness can restrict work and leisure activities, cause sleep disruptions and may result in 
high levels of anxiety and depression. 2, 3 This has lead to a growing interest, to assess the 
Health–Related Quality of Life (HRQoL) in asthmatics, and since the 1990’s there has been a 
steady increase in published studies in this field. The aim of this review is to examine the 
results of studies, which have evaluated the impact of asthma on HRQoL. A MEDLINE 
search was undertaken using the keywords: 
 Asthma and Quality of Life or Health Related Quality of Life; 
 Asthma and SF-36 questionnaire; and 
 Asthma and Rand SF-36 questionnaire. 
Furthermore, review articles that where identified in the process where assessed for additional 
citations.  
 
1. Health-Related Quality of Life 
 
HRQoL is a multidimensional concept that incorporates psychological, social and physical 
dimensions of health. 1 HRQoL refers to the impact of different disease processes or treatment 
regimes on a person’s emotional, social and physical domains of health, and how this limits 
the individuals’ ability to function in the ordinary tasks. Each of these domains of health 
evaluate objective functioning, that can be measured by an observer and the patient, and 
subjective wellbeing, that can be measured by the patient only, such as level of distress, pain 












researchers to assess the impact of different diseases and treatment in a comprehensive 
manner, by integrating objective functioning and patients subjective wellbeing, thereby 
shifting the focus from a purely disease-centred approach to a more patient-centred approach.7 
This kind of approach is more in line with the World Health Organisation (WHO) definition 
of health in which health is: “ a state of complete physical, mental and social well-being and 
not merely the absence of disease and infirmity”. 8 The WHO’s definition provides a holistic 
concept of health and implies that the focus of health care should not be simply to eradicate 
the cause of a particular disease or control of symptoms, but also to ensure, that patient’s 
social and psychological well-being is adequately preserved. 9 
 
Measuring HRQoL in asthmatics is important, given that the traditional clinical outcome 
measures for asthma, such as the forced expiratory volume in one second (FEV1), non-
specific bronchial hyper-responsiveness, and medication use, are only moderately associated 
with HRQoL.10 This suggests, that these measures do not adequately capture some important 
dimensions of individuals suffering from asthma, which can have a major influence on 
HRQoL. These include the patient’s life experiences, socio-economic status, emotional status, 
health beliefs, perception of symptoms, and expectations of health.11 Another reason for 
measuring HRQoL, is that any two individuals with the same disease process may have very 
different qualities of life, as their expectations of health, and their ability to cope with the 
limitations and disability, will impact on their perceptions of health.11 Thus, patients who have 
a chronic disease such as asthma, measuring  HRQoL, in addition to the traditional measures, 
provides a more meaningful way to determine the impact of health care, given that asthma can 














2. Measuring HRQoL 
 
There are two types of HRQoL measures: the generic measure and the disease specific 
measure (Table 1). A generic measure can be applied to general or specific populations, in 
order to assess the impact of a range of different diseases or treatment regimes. One of the 
main features of a generic measure is that it allows for the assessment of many dimensions of 
health in a comprehensive manner and removes the need to select specific dimensions for any 
particular disease. Furthermore, generic measures can be useful in comparing the findings of 
different diseases or conditions. However, one of the main drawbacks of generic instruments 
is that they are less responsive to clinical changes. 12, 13 Unlike the generic measures, the 
disease specific measures have superior responsiveness and discriminating ability, because the 
disease specific measures are specifically tailored to the problems of the patient, by including 
only the relevant dimensions of a particular disease. The main drawback of disease specific 
questionnaires is the lack of comparability of the results from different diseases or 
conditions.13 Irrespective of which measurement instrument is selected, an important 
consideration when choosing an instrument to assess HRQoL, is that the instrument should be 
valid, reliable and responsive. Moreover, investigators are not restricted to using generic or 
disease specific questionnaires, since both types of questionnaires can be used in combination 














Table 1. Disease-specific and generic questionnaires used in adult patients with asthma. 
Questionnaire  type       Diseases 
 
 Disease specific Questionnaires 
 
 
Asthma Quality of Life Questionnaire (AQLQ)15    Asthma 
Mini-Asthma Quality of Life Questionnaire (Mini-AQLQ)16    Asthma 
St. George’s Respiratory Questionnaire (SGRQ)17    Asthma,COPD 
Modified Marks Asthma Quality of Life Questionnaire (AQLQ-M)18    Asthma 
Quality-of –Life for Respiratory Illness Questionnaire (QOL-RIQ) 19    Asthma,COPD 
Living with asthma Questionnaire(LWAQ) 20    Asthma 
Airways Questionnaire (AQ20)21    Asthma 
Integrated Therapeutics Group Asthma Short Form  (ITG-ASF) 22    Asthma 





MOS Short-Form 36 questionnaire (SF-36)24   All diseases 
MOS Short-Form 12 questionnaire (SF-12)25   All diseases 
Sickness Impact Profile Questionnaire (SIP)26   All diseases 
Nottingham Health Profile Questionnaire (NHP)27   All diseases 
Euro Quality of Life Questionnaire (EuroQOL)28   All diseases 
Quality of Well-being Scale (QWB)29   All diseases 
 
3. Determinants of HRQoL in asthmatics 
 
3.1. Age  
There have been inconsistent reports on age and HRQoL in asthmatics. Some studies have 
shown age to be a contributory factor on HRQoL in asthmatics, whereas other studies have 
reported findings to the contrary. Juniper et al found that younger asthmatic patients had 
significantly diminished HRQoL compared to the older asthmatic group. 2 This was attributed 
to greater adaptation to the limitations caused by asthma amongst the elderly, resulting in 
elderly asthmatics being less distressed by their asthma then younger adults. 2 In contrast, 
Bousquet et al found that, older asthmatic patients reported poorer HRQoL in the SF-36 












asthmatics. 30 Findings from other studies are consistent with Bousquet et al. 31, 32 It is argued 
that among the elderly, co-morbidity may well account for the association between age and 
poorer HRQoL. 33 Erickson et al, on the other hand, found that age was not significantly 
associated with HRQoL in asthmatics, using both AQlQ and the SF-36 questionnaire.34 Apter 
et al findings were similar to Erickson et al. 11 
 
3.2. Sex/gender  
Several epidemiological studies have demonstrated a relationship between sex/gender and 
HRQoL, in which female asthmatic patients reported a poorer HRQoL and symptoms 
compared to male asthmatics. 30, 35-40 In a follow-up study by Sundberg et al, female 
asthmatics patients, scored significantly lower with LWAQ and in the SF-36 domains of 
Physical Functioning and General Health compared to male asthmatics. 35 In a population 
based study, Osbourne et al’s found that asthmatic women between the ages of 35-55 years 
reported significantly poorer HRQoL in the SF-36 domains Physical Functioning, Social 
Functioning and Bodily Pain compared to asthmatic men. 36   Wijnhoven et al study found 
that women with asthma rated a poorer HRQoL for both QOL-RIQ and NHP 
questionnaires.37 
 
 Despite, the abundance of literature assessing the relationship between sex/gender and 
HRQoL in asthmatics, very few studies explore the reasons for these observed sex/gender 
differences. Wijnhoven  et al argued, that the sex/gender differences cannot be accounted for 
by differences in ‘objective disease severity’, since women had generally higher pulmonary 
function levels than men, but the differences are likely to be explained by ‘subjective disease 
parameters’. Women reported more severe dyspnoea, and a higher use of medication 












disorders, and asthmatic women experience far greater psychological disorders, such as mood 
and anxiety disorders, compared to men, suggested that women may have more severe 
asthma in terms of ‘subjective disease parameters’. 37 Belloch et al also found in their study, 
that dyspnoea was the best predictor of HRQoL in asthmatic women, and this they argue may 
be related to, the higher anxiety and depression scores in women compared to men. Belloch 
et al further argue that the contribution of emotional disorders on HRQoL in asthmatic 
women is further compounded by age. Hence, as women aged, they experience more 
emotional disorders, thereby further diminishing their HRQoL compared to men. 38 
 
3.3. Smoking status   
There appears to be a significant negative association between smoking status and HRQoL in 
individuals with asthma. In a longitudinal study by Sippel and colleagues, current smokers 
and ex-smokers reported significant impairment in their HRQoL, compared to non-smokers. 
Current smokers reported impairment in HRQoL for two of the five domains of the AQLQ, 
whereas ex-smokers reported impairment in HRQoL for all the five AQLQ domains, 
compared to non-smokers. With regard to the SF-36 health survey instrument, both current 
and ex-smokers rated poor HRQoL in the following SF-36 domains: Physical Functioning, 
Mental Health, Vitality and General Health, compared to non-smokers.41 Ford et al, also 
found strongly negative associations between smoking and HRQoL in asthma.33. 
 
3.4. Socioeconomic status  
Given the extensive literature on socioeconomic status (SES) and health, there appears to be a 
lack of consensus on what actually constitutes SES in health care research.42 Studies that 












definitions of SES. However, despite this limitation, studies have consistently shown SES to 
impair HRQoL in asthmatics.11, 43 
 
SES can be measured at an individual level and/ or at an area level. At an individual level, 
SES can include variables such as: level of education, occupation, household income and 
type of health insurance, all of which reflect social and economic status. At an area level, 
SES includes variables such as: income measures, education patterns, employment rates, 
average home values and the level of social grants provided. The inclusion of SES, both at an 
individual level and at an area level, is particularly relevant in asthma research. At individual 
level exposures that are directly related to SES such as high levels of respiratory irritants or 
sensitizers in lower-paying occupations; exposures from the use of blomass fuels or cooking 
stoves; and environmental tobacco smoke exposures, are likely to adversely affect asthmatics. 
Similarly, at an area level, exposures relating to SES such as poor air quality due to traffic 
density, high levels of pollution due to close proximity to industrial area, and social –
community stressors are also likely to negatively affect asthmatics. 43 
 
Blanc et al, assessed the relationship between SES, at an individual level (level of education, 
Annual income and employment status) and at an area level (e.g. income below poverty level 
%, Unemployment %, single parent household %) on HRQoL using SF-12 PCS and AQLQ-
M in asthmatics. The study found, that lower area level SES was significantly associated with 
poorer General Health, as measured by SF-12 PCS scale and resulted in significant 
impairment in HRQoL as measured by AQLQ-M.43 Apter et al, also found a strong 
association between individual level SES (education level, household income, occupational 
status and type of health insurance) and HRQoL. The study demonstrated that individuals 












asthma control, which contributed significantly to impaired HRQoL in both the AQLQ and 
Physical Component Summary (PCS) of the SF-36.11  
 
3.5. Asthma Severity 
It is well known that individuals with severe asthma are likely to encounter greater physical 
limitations and experience different levels of impairment, compared to individuals with mild 
asthma.9 Epidemiological studies have consistently shown a strong relationship between 
asthma severity and impaired HRQoL. 9, 30, 34, 44, 45 However, the strength of the association 
between asthma severity and impaired HRQoL is largely dependent on the criterion used to 
define asthma severity. Studies that have used purely objective measures such as forced 
expiratory volume in one second (FEV1), have found poor association between asthma 
severity and HRQoL, compared to studies that have used both subjective (diary cards of 
symptoms, symptom intensity and the use of β2-agonist) and objective measures of asthma 
severity.7 
 
Ehrs et al found no relationship between asthma and HRQoL using the AQLQ. The study 
used objective measures of asthma such as lung function, reversibility to a bronchodilator, 
bronchial hyper responsiveness, and exhaled nitric oxide. 46 The findings of the study 
confirms the general consensus, that asthmatic patients are more likely to be distressed and 
are more concerned about the symptoms of their asthma, and the limitations caused by their 
asthma (subjective dimensions) as opposed to objective dimension of their asthma. 7 Moy et 
al’s study, also demonstrated this finding. The study assessed the relationship between 
clinical predictors of HRQoL and asthma severity (defined using, FEV1, diary card of 
symptoms and symptom intensity as recorded by patients and the number of rescue puffs of 












mild asthma and moderate to severe asthma reported poor HRQoL. However, patients with 
moderate-severe asthma reported significantly poorer HRQoL compared to patients with mild 
asthma. Furthermore, rescue puffs of β-agonist and symptom intensity of shortness of breath, 
wheeze, and cough were found to be significant predictors of HRQoL in patients with mild 
asthma whereas, in patients with moderate-severe asthma, only symptom intensity of 
shortness of breath and cough were significant predictors of HRQoL. 44 
 
The study by Muraki et al, found that patients with moderate to severe asthma rated poorer 
HRQoL scores for the AHQ subscales of High asthma symptoms, Factors which Worsened 
Symptoms, Emotion, and Daily Activity and the SF-36 domains of, Physical Functioning. 45 
Similarly, Reid et al in their study of moderate-severe asthma patients, using the SF-36 
questionnaire, found the SF-36 subscales Physical Functioning, General Health and Vitality 
were profoundly affected in patients with severe asthma. 9 Other studies that have used the 
SF-36 questionnaire have reported similar findings, in which patients with moderate to severe 
asthma experienced significant impairment in their physical health and less so in their 
psychological health. 30, 34 
 
Although, one would expect greater psychological impairment in moderate to severe 
asthmatics, given the high level of impairment in physical health, this is not borne out in the 
literature. Diminished physical functioning can lead to restrictions in work and leisure 
activities and can create higher levels of frustration and anxiety. However, it is argued that 
asthmatics patients adapt to the physical limitations caused by their disease. Moreover they 
reduce their expectations for their health and activities.9 Furthermore, ten Brinke et al argue, 
that it is more likely that morbidity and costs of asthma may be related to psychological 













 3.6. Asthma treatment 
Studies, which have looked at the impact of treatment guidelines [National Institute of Health 
International asthma guideline (NIH), and Global Initiative for Asthma (GINA) on HRQoL, 
have found significant improvements in the HRQoL amongst asthmatics. 48-51 
 
Bateman et al found that well–controlled asthmatics as defined by the GINA guidelines 
experienced significant improvements in their HRQoL. The study found that irrespective of 
asthma severity, well-controlled asthmatics scored higher for all AQLQ domains over an 8-
week period. Some patients achieving scores of 7 (1 = severe impairment and 7 = no 
impairment) on the AQLQ. More importantly, the study found that patients receiving 
Salmeterol/ fluticane propionate combination therapy (SFC) experienced significant 
improvement in their HRQoL irrespective, of whether they were well controlled or not. 48 
Pont et al compared the HRQoL of asthma patients receiving treatment according to NIH and 
those patients receiving non-guideline treatment and, found patients that received guideline 
treatment, had superior AQLQ HRQoL compared to patients with non-guideline treatment. 40 
Other studies have also reported similar findings. 50, 51 
 
3.7. Asthma and co-morbidity  
Studies have demonstrated the adverse impact of co-morbidity on HRQoL amongst those 
suffering from chronic diseases, particularly amongst the elderly. Evaluation for co-morbidity 
in patients with asthma is important for several reasons. Failure to assess co-morbidity in 
asthma can distort the true relationship between asthma and HRQoL. Equally important is to 













3.7.1. Allergic rhinitis  
Allergic rhinitis and asthma frequently coexist. Indeed, in recent years the united airways 
concept has gained prominence, highlighting the similarities in pathophysiology between 
allergic rhinitis and asthma.52 Numerous studies have assessed the relationship between 
asthma and allergic rhinitis and HRQoL. 52-54 In a study by Kalpaklioglu and colleagues, 
which examined the impact of allergic rhinitis on asthma and HRQoL, found that patients 
with allergic rhinitis experienced significantly greater impairment for the SF-36 scales Role 
Physical and Mental Health, whereas, patients with asthma reported significant impairment in 
Physical Functioning. Furthermore, the study found that allergic rhinitis did not further 
impair HRQoL in asthmatics.52 In a population based study by Leynaert and colleagues, 
which examined the impact of asthma on allergic rhinitis, found that patients with allergic 
rhinitis experienced greater impairment in their mental health. Patients with allergic rhinitis 
scored significantly lower for the SF-36 subscales General Health and Vitality and for the 
Mental Component Summary (MCS). Moreover, the study found that in patients with both 
allergic rhinitis and asthma, there was further impairment in physical health. Thus, patients 
with allergic rhinitis and asthma experienced HRQoL impairment, not only in the SF-36 
domain General Health, Vitality, but also in the Physical Functioning domain. 53 
 
3.7.2. Non respiratory co-morbidity. 
Wijnhoven et al is one of few studies, which examines, the impact of co-morbidity on 
HRQoL in asthmatic patients, using both the QoL-RIQ and NHP questionnaires. The study 
reported that co-morbidity is an important determinant of both QoL-RIQ and NHP HRQoL 
among asthmatics, and that, the presence of more than one co-morbidity, significantly 
decreases the HRQoL in asthmatics. In addition, the study demonstrated that asthmatics with 












HRQoL scores. Furthermore, asthmatics with musculoskeletal disorders had the poorest NHP 
HRQoL scores. The impact of diabetes and other chronic diseases were however, not 
significant; but, this may be due to the small sample size of this group. 55 
 
One of the major limitations of the Wijnhoven study was that it did not examine the 
contribution of psychological disorders on HRQoL in asthmatics. Asthmatic patients are 
known to report higher rates of anxiety and depression compared to the general population.56 
Moreover; studies have shown the adverse effect of depression and anxiety on HRQoL in 
asthmatics. 57, 58 Asthmatics with more depressive symptoms rate significantly lower HRQoL 
scores compared to asthmatics with less depressive symptoms. 57 
 
4. Summary 
This review has highlighted some of the important literature on HRQoL in allergic asthma. 
sex/gender, age, smoking status, socioeconomic status, asthma severity, asthma treatment and 
co-morbidity with asthma are found to be predictors of HRQoL among asthmatics. Future 
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HEALTH-RELATED QUALITY OF LIFE AMONG MACASSAR 
RESIDENTS WITH PERSISTENT LOWER RESPIRATORY 
SYMPTOMS AND/OR ASTHMA FOLLOWING A SULPHUR 





Aim: To determine the health-related quality of life (HRQoL) in Macassar residents with 
persistent lower respiratory symptoms and/or asthma (PLRS and/or asthma), six years after 
exposure to sulphur dioxide vapours emanating from a sulphur stockpile fire disaster. 
Methods: A cross-sectional analysis of responses from affected residents was conducted six 
years after the incident. Information was obtained from a dataset of 4000 respondents to an 
interviewer-administered questionnaire that included medical history, respiratory symptoms 
and HRQOL using the Medical Outcomes Study Form 36 (SF-36). The respondents surveyed 
six years after the fire, provided information for three different time points, prior to, one year 
and six years after the fire. 
Results: A total of 246 records of residents, 74 with PLRS/asthma and 172 without 
PLRS/asthma were analysed. The mean age of the symptomatic group was 49 (SD:12) years 
and 47 (SD:13) years in those without PLRS and/or asthma. Approximately 60% of the 
residents were current and ex-smokers in both groups. A greater proportion were women 
(61.3%) and 68% of women reported PLRS/asthma. The mean SF-36 scores were 
significantly lower for the symptomatic group in the Physical Functioning (24 vs. 39), Role 
Physical (33 vs. 48) and General Health domain (24 vs. 37). Residents with PLRS/asthma, 












1,09-3,55) and General Health (OR=7,07; CI 2,88-17,35) at year 1 and General Health 
(OR=3,50; CI 1,39-8,79) at year 6, compared to those without PLRS and/or asthma. 
Residents with co-morbid RUDS (reactive upper airways dysfunction syndrome) 
demonstrated even stronger associations for General Health (OR=7,04; CI 1,61-30,7) at year 
1 and at year 6 (OR=8.58; CI 1,10-65,02).  
Conclusion: This study highlights the long-term adverse impact on HRQOL among residents 
with lower and upper airways disease following a sulphur stockpile fire disaster.  
 




PLRS and/or asthma - Persistent lower respiratory symptoms and / or asthma 
RADS - Reactive Airways Dysfunction Syndrome 
RUDS - Reactive Upper Airway Dysfunction Syndrome 
COPD - Chronic Obstructive Pulmonary Disease 
HRQoL - Health-related quality of life 
SF-36 - SF-36 Health Survey 
PF – Physical functioning 
RP – Role physical 
BP – Bodily Pain 
GH – General Health 
V – Vitality 
SF – Social Functioning 
RE – Role Emotional 














Asthma is a chronic disease, which is known to impair psychological, physical and emotional 
well- being [1] Symptoms of asthma can restrict work and leisure activities, cause sleep 
disruptions and may lead to high levels of frustration, anxiety and depression. [2-3] This has 
lead to a growing interest, in the relationship between Health–Related Quality of Life 
(HRQoL) and asthma. HRQoL refers to the impact of different disease processes or treatment 
on an individual’s emotional, social and physical domains of health, and how this limits the 
individual’s ability to function in the ordinary tasks. [4] HRQoL research therefore enables 
health care practitioners and researchers to assess the impact of different diseases and 
treatment in a comprehensive manner, by integrating objective functioning and patients’ 
subjective wellbeing, thereby shifting the focus from a purely disease-centred approach to a 
more patient-centred approach. [5] 
 
Measuring HRQoL in asthma is important, given that the traditional outcome measures for 
asthma, such as the forced expiratory volume in one second (FEV1), bronchial hyper-
responsiveness, and medication use are only moderately associated with HRQoL. [6] This 
suggests that these measures do not adequately capture some important dimensions of 
asthmatics, which can have a major influence on their HRQoL. These include individual’s 
life experiences, socio-economic status, emotional status, health beliefs, perception of 
symptoms, and expectations of health. [7] In individuals with chronic disease such as asthma, 
measuring these factors that influence HRQoL in addition to the traditional measures, 
provides a more meaningful way to determine the impact of health care, given the emotional, 














Numerous studies have addressed the impact of asthma on HRQol, using well-validated 
instruments. [8-10] Most studies have consistently found asthma to overwhelmingly impair 
the physical health of those suffering from asthma. [8-11] The relationship between age and 
HRQoL in asthma remains inconclusive. Some studies have shown that older asthmatics have 
poorer HRQoL. [9, 13] In contrast, others suggest, that older asthmatics are less distressed by 
their asthma, due to adaptation to the limitations caused by their asthma, than younger 
asthmatics. [2,14] Furthermore, there appears to be a sex/gender differential, in which female 
asthmatics experience significantly poorer HRQoL compared to their male counterparts. 
[9,15,16] A strong association has been found between smoking status and HRQoL in 
individuals with asthma. Current smokers and ex-smokers were found to experience 
significantly poorer HRQoL, compared to non-smokers. [17,18]. The adverse impact of 
socioeconomic status (SES) on HRQol in asthma, has also been documented, in which, 
individuals from lower SES (both at an ‘individual level’ and at ‘area level’) reported 
significantly impaired HQRoL [7, 19] Strongly positive associations have been observed 
between severity of asthma and HRQoL. Individuals with severe asthma are more likely to 
encounter greater physical limitation and impediments, compared to individuals with mild or 
moderate asthma. [8,9] Significant improvements in HRQoL have been noted in patients on 
standard treatment guideline regimes[1997 National Institute of Health International asthma 
guideline (NIH) and Global Initiative for Asthma (GINA)], compared to non-guideline 
treatment regimes [20,21] In terms of co-morbidity, allergic rhinitis was found not to impair 
HRQoL in asthmatics. [22] However, asthma was found to significantly impair HRQoL in 
patients with allergic rhinitis [23] Furthermore, other chronic diseases such as hypertension, 
cardiac diseases, diabetes, arthritis and psychological disorders, have all been found to 













On the 16-17 December 1995, 15 000 tons of sulphur ignited, resulting in exposure of high 
levels of sulphur dioxide (SO2) vapours amongst the Macassar residents and the surrounding 
residential and farming areas.[25] Approximately, 30,000-40,000 people were living in 
Macassar at the time of the disaster. This kind of chemical disaster, namely the burning of a 
sulphur stockpile, was the first of its kind. Elsewhere in the world, major chemical disasters 
have also been reported, the Bhopal disaster in India and the Seveso disaster in Italy. The 
Bhopal disaster, was associated with exposure to methyl isocyanate gas resulting in a wide 
range of health effects that included eye problems, respiratory difficulties, immune and 
neurological disorders, cardiac failure, female reproductive problems and birth defects among 
children born to affected women. [26] The Seveso disaster resulted in exposure to high levels 
of 2,3,7,8-tetrachlorodibenzo-p-dioxin, with reported health effects that included chloracne, 
peripheral neuropathy and liver enzyme dysfunction.  [27] 
 
Following the sulphur fire, the Macassar disaster project clinic was established with legal 
assistance from the Legal Aid Board in South Africa to assist residents that were affected by 
this disaster. Approximately, 4000 residents attended the clinic reporting various organ-
specific system complaints perceived to be associated with exposure to the sulphur fire. 
These complaints were diverse affecting the ocular-nasal, respiratory, gastro-intestinal, 
dermatological and neuro-psychiatric systems. A large proportion of the residents had 
respiratory complaints, having aggravation of their asthma or new onset irritant induced 
asthma (reactive airways dysfunction syndrome – RADS). It is this subgroup of individuals 
that are the subject of the current study. The aim of the study was to determine the HRQoL in 












(PLRS and/or asthma), six years after exposure to vapours emanating from a sulphur 
stockpile fire disaster. 
 
Methods 
Recruitment and sample 
A cross-sectional analysis of data collected over a period of 24 months (May 2001 to May 
2003) was conducted. The study population dataset originally consisted of 4000 residents of 
Macassar who presented six years later to the Macassar disaster project clinic for a medical 
evaluation following health complaints as a result of acute exposure to SO2 vapours at the 
time of fire. Within this group, there were residents with pre-existing asthma who 
experienced further aggravation of their asthma and a proportion of residents who developed 
new onset of persistent lower respiratory symptoms and/or asthma (PLRS and/or asthma) 
(Figure 1).  
 
Power calculations were conducted using STATA version 8 statistical software. Based on 
these calculations a sample of 74 adult residents with PLRS and/or asthma and 172 adult 
residents without PLRS and/or asthma were selected. This was based on having > 80% power 
and 95% confidence and a background exposure prevalence of 25% and 50% among 
residents with PLRS and/or asthma and residents without PLRS and/or asthma respectively. 
All residents with PLRS and/or asthma were selected and a random sample of residents 
without PLRS and/or asthma were selected. All the residents participating in the study 
provided written consent and the research protocol was approved by the Research Ethics 




























Information from residents was obtained through a structured interviewer-administered 
questionnaire. The first part of the questionnaire was used to obtain data pertaining to 
demographic characteristics, exposure history, co-morbidity and health symptoms 
experienced prior to, at year 1 and 6 years after the disaster. Additional information on socio-
economic status and health care utilisation was not collected from the participants, as these 
variables were not considered to be differentially distributed in a major way among the 
residents of this working class area. The second part of the questionnaire collected data on 
HRQoL and consisted of the generic health status questionnaire, the SF-36 health survey. [28] 
The SF -36 questionnaire incorporates eight scales, viz. (1) physical Functioning (PF), (2) 
Role – Physical (RP), (3) Bodily Pain (BP), (4) General Health (GH), (5) Role – Emotional 
(RE),  (6) Mental Health (MH),  (7) Vitality (VT), (8) Social Functioning (SF).  
 
Definition of PLRS and/or asthma 
Persistent lower respiratory symptoms included wheeze, tight chest, or a doctor diagnosis of 
obstructive lung disease (irritant induced asthma, asthma aggravation and COPD), present at 
year 1 and 6 year after the incident. The presence of current active pulmonary TB within one 
year of these time points was regarded as an exclusionary criterion. 
 
Statistical analysis 
Statistical analysis was performed using STATA version 10 (StataCorp, College Station, TX, 
USA). The Rand 36-item scoring procedure was used. A two-step scoring process was 
implemented, the first step involved recoding some items, and step 2 involved averaging the 
items in the same scale. The scores from all the eight scales range from 0 to 100 with a high 













The eight scales of SF-36 HRQoL were defined as the dependant variables and the main 
predictor of interest was PLRS and/or asthma. The other covariates considered were age, 
sex/gender, smoking, current treatment of asthma, previous history of pulmonary TB, 
hypertension, cardiac disease, diabetes, arthritis, depression and anxiety. Normality of data 
was tested using Shapiro Wilk test. The non-parametric Mann-Whitney test was conducted to 
test for the differences in the scores of the eight SF-36 scales between residents with and 
without PLRS and /or asthma, 6 years after the fire. The mean differences for seven of the 
SF-36 scales (missing data for scale Physical Functioning prior to the fire and year 1) were 
calculated by subtracting the SF-36 HRQoL scale scores for year 1 from the baseline scores 
prior to the fire and similarly, for year 6, stratified according to the presence and absence of 
PLRS and/or asthma.  
 
Univariate and stepwise multiple linear regression analysis (with the eight SF-36 scales as the 
dependent variable) was performed, to determine the relationship between the eight SF-36 
scales scores and the presence of the predictor of interest and the other covariates: age, 
sex/gender, smoking status, treatment for asthma, Pulmonary TB, Reactive Upper Airways 
Dysfunction Syndrome (RUDS), hypertension, cardiac disease, diabetes, arthritis, depression 
and anxiety. Multivariate logistic regression models adjusted for age, sex/gender, smoking, 
pulmonary TB, cardiac history and depression (anxiety was not included in the model as it 
was found to be highly correlated with depression) were used to determine the contribution of 
PLRS and/or asthma towards decline in HRQoL with as well as without co-existing RUDS 
morbidity. A decline of more than 5 points in the SF-36 (0-100 scale) was considered to be of 














The demographics characteristic (age, sex/gender and smoking status) were very similar 
between residents with PLRS and/or asthma and those without PLRS and/or asthma; except 
for the previous history of pulmonary TB, which was more prevalent, among those with 
PLRS and/or asthma. The mean age of the 246 respondents was between 40-50 years with 
almost 60% being current or ex-smokers and a greater proportion were females (61.3%). A 
significant amount of residents (72.7%) reported suffering from at least one other chronic 
disease. The prevalence of depression and anxiety was similar, while cardiac disease and 
diabetes more common in the residents with PLRS and/or asthma and musculo–skeletal 
diseases more prevalent in residents without PLRS and/or asthma (Table 1). 
Table 1: Demographic and health related characteristics of Macassar residents stratified according to the 















A significant proportion of women (68%) reported PLRS and/or asthma. Of the 74 residents 
with PLRS and/or asthma, 63% reported a doctor diagnosis of reactive airways dysfunction 
syndrome (RADS), 32.4% asthma aggravation and 42% reactive upper-airways dysfunction 




Figure 2. Prevalence (%) of upper and lower respiratory disorder diagnosis in Macassar residents 
reporting PLRS and / or asthma (n =74) 6 years after the fire 
 
RADS – Reactive Airways Dysfunction Syndrome, COPD – Chronic Obstructive Pulmonary Disease 














Approximately, 43% of residents with PLRS and/or asthma also had RUDS and residents 
with RUDS all had co-existing RADS. A higher proportion of residents with asthma had 
moderate to severe asthma [28% of the residents with PLRS and/or asthma had severe asthma 
(FEV1 <50% predicted), 18% had moderate asthma (FEV1: 51-60% predicted)] compared to 
mild asthmatics [37% had mild asthma (FEV1: 61-80% predicted)]. Only 60% of the 
residents were on current asthma treatment at 6 years. 
 
The overall mean scores for each of the SF-36 scale at year 6 were Physical Functioning 29 ± 
27.3,  Role Physical 44 ± 48.3, Bodily Pain 64 ± 30.9, General Health 33 ± 24.8, Vitality 51 
± 20.6, Social Functioning 60 ± 28.6, Role Emotional 49 ± 49.3 and Mental Health 51 ± 20.6. 
At year 6 residents with PLRS and/or asthma scored lower for all domains of SF-36 with the 
exception of Bodily Pain scale, compared to residents without PLRS and/or asthma, 6 years 
after the fire. A similar pattern was observed for the scores at year 1 (Appendix 5). The 
scores representing the physical health component scales viz. Physical Functioning, Role-
Physical and General Health were significantly lower in residents with PLRS and/or asthma, 
p < 0.05 (Table 2).  
 
Furthermore, the mean difference in scores were significantly lower for Role Physical (-36 
vs. -24; p=0.036) and General Health (-50 vs. -30; p<0.001) at year 1, and for General Health 















Table 2. Health-related quality of life SF-36 scale scores of Macassar residents stratified according to the presence of persistent lower 
respiratory symptoms and/or asthma 6 years after the fire (n=246) 
 
  Physical Functioning          Role Physical           Bodily Pain       General Health 
  Mean (SD)     Median (IQR)   Mean (SD)   Median (IQR)   Mean (SD)   Median (IQR)   Mean (SD)   Median (IQR) 
PLRS/Asthma 24±25.1          15 (0-35)          33 ± 45.9      0 (0-100)  67 ± 30.8      78 (33-100)          24 ± 17.8      19 (13-32) 
No PLRS/Asthma 39±28.5 35 (18-35)  48 ± 48.7 0 (0-100)  67± 31.0 78 (33-100)  37 ± 25.9 32 (13-56) 
p-value <0.001     0.024     0.797     < 0.001   
              Vitality   Social Functioning       Role Emotional        Mental health 
  Mean (SD)     Median (IQR)   Mean (SD)   Median (IQR)   Mean (SD)   Median (IQR)   Mean (SD)   Median (IQR) 
PLRS/Asthma 50 ± 20.1        50 (35-65)           57 ± 28.8      55 (33-80)            46 ± 49.2      0 (0-100)     62 ± 26.9 60 (36-88)          
No PLRS/Asthma 52 ± 20.6 50 (40-65)  62 ± 28.2 68 (43-80)  51± 49.1 63 (0-100)  63 ± 24.9 60 (44-84) 



















Multivariate linear regression models demonstrated that all predictors of HRQoL investigated 
were inversely correlated with the SF-36 scale scores (Table 3). Furthermore, in addition to 
PLRS and/or asthma, age, sex/gender, depression, anxiety and cardiac disease was the most 
important determinants of physical health-related HRQoL scores, while age, sex/gender, 
smoking status, depression and anxiety were important predictors of mental health-related 
HRQoL scores. Aside from depression and anxiety, residents with PLRS and/or asthma were 
more likely (p<0.05) to have lower scores for the following three SF-36 scales Physical 
Functioning (-13.13), Role-Physical (-13.9) and General Health (-12.84) at year 6. The 
Physical Functioning model explained the greatest variability in the HRQoL scores (33%). 
Further, residents with RUDS were more likely to have lower scores for the scale General 
Health model [β = -9.57 (p=0.04)]. 
 
A significantly larger proportion of residents with PLRS and/or asthma, reported clinically 
significant decline (5 points) in scores for the SF-36 scales than the asymptomatic group at 
year 1 viz. Role- Physical (40.5%  vs.27.3 %  p=0.04) ) and General Health (92% vs. 62% 
p<0.001). Similarly, a significantly higher proportion of the residents with PLRS and/or 
asthma experienced a significant decline in their General Health, compared to  residents 















Table 3. Significant determinants of health-related quality of life according to SF-36 scale scores of Macassar residents 6 years after fire (n=246) in multivariate 
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Logistic regression models demonstrated a clinically significant decline in scores of SF-36 health 
scales, Role Physical (OR = 1,97; CI 1,09 - 3,55) and General Health (OR= 7.07; CI 2,88 - 17,35) 
at year 1 and General Health (OR=3.50; CI 1,39 - 8,79) at year 6, in residents with PLRS and/or 
asthma (Table 4). Similarly, residents with PLRS and/or asthma with co-existing RUDS 
experienced a clinically significant decline in their HRQoL for the SF-36 scale General Health 
(OR=7.04; CI 1.61- 30.7) at year 1 and General Health (OR=8.58; CI 1, 10 – 65, 02) at year 6. The 
model with RUDS only, yielded similar results to the combined model since RUDS did not occur 
on its own (data not shown).  
 
Discussion 
This study has shown that residents who developed PLRS and /or asthma, as a result of exposure to 
SO2 vapours, in an environmental disaster, scored significantly lower (p<0.05) for the SF-36 scales 
Physical Functioning, Role-Physical and General Health, compared to residents without PLRS 
and/or asthma 6 years after the incident. PLRS and/or asthma, was found to be strong determinant 
of physical health as opposed to mental health related quality of life. Residents who had co-morbid 
RUDS, scored significantly lower (p=0.04) for the SF-36 subscale General Health.  
 
In this study, residents with PLRS and/or asthma reported lower General Health perception, in that 
they perceived their health to be poorer and believed that, it would get worse over time. PLRS 
and/or asthma was also associated with lower scores in Physical Functioning and Role Physical 
indicating that they experienced limitations in performing physical activities, daily activities of 
living or work, at 6 years. Furthermore, this study found that residents with PLRS and/or asthma 
were more likely to experience (>5 points from baseline) decline in their HRQoL for the SF 














Table 4. Determinants of  decline in health-related quality of life  in physical health according to SF-36 subscale  scores of Macassar 
residents at 1year and  6 years after fire (n=246) in  multivariate logistic regression models 
   
                                                                     
                                                  Decline in SF – 36 scores after  1 year 
                                                              Odds ratio (CI)                       
                                                      
                         Decline in SF – 36 scores after  6 years   
                                         Odds ratio (CI)  
     
   Role Physical 
 
               
     Bodily pain  
        
    General health      
 
  Role physical 
 
                
       Bodily pain   
      
  General health      
       




  1.97 (1.09 – 3.55)* 
 
  1.24 (0.70 – 2.21) 
 
   7.07 (2.88 – 17.35)*** 
 
 1.59 (0.89 – 2.84) 
 
      1.05 (0.59 – 1.84) 
 






  1.82 (0.84 – 4.15) 
 
  0.95 (0.42 – 2.13) 
 
   7.04 (1.61 – 30.7) ** 
  
1.65 (0.74 – 3.79) 
 
      0.84 (0.38 – 1.84) 
 
 8.58 (1.10 – 65.02)* 
 
 
Each odds ratio is a separate model adjusted for age, sex, smoking status, pulmonary TB, depression and cardiac disease. *: p<0.05; **: p<0.01; ***: p<0.001 















Health (OR=3,50) at year 6. Thus, residents with PLRS and/or asthma experienced 
significant impairment in physical health at 6 years after the fire and over time. This may be 
explained by the high proportion of moderate to severe asthmatics (46%) relative to mild 
asthmatics (37%), in this study. Previous studies have demonstrated significantly greater 
impairment in HRQoL in physical health in severe to moderate asthmatics compared to mild 
asthmatics [8,9,10,11].. Muraki et al reported that patients with severe asthma experienced 
poorer HRQoL for the SF-36 scale Physical Functioning. [11] Similarly, other studies have 
also reported effects on physical health among asthmatics. [9, 10] Contrary to our findings, 
Osman et al’s study of mild asthmatics reported both physical and mental health related 
HRQoL effects. [31]. However, Sundberg et al found no significant difference in decline in 
the SF-36 HRQoL among asthmatics. [32] It is argued that individuals with chronic disease 
such as asthma employ coping mechanisms, in order to deal with their asthma, by reducing 
their expectations for their heath and activities. [33] Thus, it may well be the case that 
residents with severe to moderate PLRS and/or asthma may have adapted to the physical 
restrictions caused by their asthma, by reducing their expectations of their health and physical 
activities, thereby creating a more positive outlook on life, and therefore were less likely to 
mental health related HRQoL effects as reported by studies of mild asthmatics. Further 
research is therefore needed in this area, to assess the relevance of the decline in HRQoL over 
time, as observed in our current study. 
 In this study, residents with persistent upper (RUDS) and lower airway symptoms reported 
poorer General Health perceptions at year 6 and over time. Leynart et al, found that patients 
with allergic rhinitis experienced greater impairment in their mental health, with significantly 
lower scores for the SF-36 scales General Health and Vitality and for the Mental Component 











experienced greater impairment in their physical health, particularly in the SF-36 domains of 
Physical Functioning and Role Physical. Hence, asthma was found to further impair HRQoL 
in patients with both allergic rhinitis and asthma. [23] Kalpaklioglu and colleagues found that 
patients with asthma experienced significant impairment in their physical health. Moreover, 
in patients with both allergic rhinitis and asthma there appeared to no further impairment of 
HRQoL. Hence, allergic rhinitis did not impair HRQoL in patients with asthma. [22] In our 
study PLRS and/or asthma and RUDS (irritant form) occurred at the same time, hence the 
pathophysiology was different from allergic rhinitis and asthma. This may well account for 
the differences in the findings of this study from previous studies.  
In this study, sex/gender was found to be strongly associated with poorer HRQoL. It is 
argued that women experience higher morbidity and poorer health perceptions than men; due 
to the social constructions of sex/gender i.e. gender roles and traits.[34] Indeed studies that 
have assessed gender differences in HRQoL among asthmatics have found asthmatic women 
to have significantly poorer HRQoL compared to asthmatic men. It has been reported that 
these sex/gender differences are likely to be explained by ‘subjective disease parameters’. 
Despite higher pulmonary function levels in women compared to men, women report more 
severe dyspnoea, and a higher use of medication. Given that women experience far greater 
psychological disorders, such as mood and anxiety disorders, compared to men, and  that 
dyspnoea is one of the main symptoms of anxiety disorders, suggests that women may have 
more severe asthma in terms of ‘subjective disease parameters’.[15] 
Some of the strengths of this study should be mentioned. This study used a well-validated 
instrument, the SF-36 health survey, which enabled the assessment of both mental and 











opportunistic study of a rare event. The Macassar disaster was the first of its kind and 
provided the opportunity to assess the impact of co-existing PLRS and/or asthma and RUDS 
on HRQoL in residents exposed to SO2 at such a large scale. 
The results of this study are subject to several limitations. Firstly, ‘self – selection’ bias was 
one of the limitation in this study, given that the entire study population was self-referred and 
not randomly selected, and may have been driven by other factors such as compensation. 
Secondly, recall bias may have occurred, given that the residents were asked 6 years after the 
interviewees were unaware of the hypothesis of the study and therefore were unlikely to 
answer questions according to the expected outcome. Furthermore, recall bias is considered 
unlikely, given that reporting would not have been differentially distributed among residents 
with and those without PLRS and/or asthma.   Nevertheless, the results for year 6 are likely to 
be more robust, given that HRQoL measured at 6 years after the fire was during the year that 
the survey was conducted. Finally, the study was potentially subject to confounding bias, 
given that data for socio-economic status (education, occupation and income) and health care 
utilisation was not collected. However, as indicated previously, these variables were 
considered not to be differentially distributed amongst the residents with PLRS and/or asthma 
and those without PLRS and/or asthma, and were not considered to have impacted on the 
results in a substantial way. 
The findings of this study highlight the public health implications in the long term. Hence, 
health care providers need to be cognisant of the impairment in physical health in residents 
with PLRS and/or asthma. Consideration needs to be given to physical limitations 
experienced by the residents affected by the disaster. These could include transport to health 












would enable the residents to overcome some of the physical limitations endured as a result 
of their asthma. Furthermore, residents may require counselling, in order to overcome the 
poor perceptions of their general health. Counselling may allow residents to adapt to the 
physical restriction caused by their asthma, by encouraging the residents to have more 




In conclusion, this study highlights the long-term adverse impact on HRQOL among 
residents reporting lower and upper airways disease following a sulphur stockpile fire 
disaster. Future studies need to focus on assessing the impact of irritant induced rhinitis and 
asthma on HRQoL among individuals affected by irritant chemical exposures following 
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Appendix 1: Macassar Questionnaire 
 
Macassar – AECI fire disaster medical claimants project, screening questionnaire - 
2001 
 
A. Demographic information 
Date:_______________________ 
Respondent:  ____ Claimant     ____ Parent or Guardian _____        
Claim no. __________________________ 
Personal information: 
Surname: ___________________________   
First name: __________________________ 
ID No.   ______________________________ 
Address:  ______________________________________________________  
______________________________________________________ 
Phone No:  (H)_______________(W)_______________ 
 
Gender:   ____ Female      ____ Male  
 













1. What was your address at the time of the fire?
______________________________________________________________
2. Where you in the Macassar area at time of the fire?  Yes__or _____No        If No, when 




3. If Yes, in which area or address were you when you became aware of the
fire?_______________________________________________________
3.1What was the time? ______________________________  
3.2 Were you ____ indoors?    _____ outside at time of detection? 
Please list your movements in the Maccasar area during the first 36 hours after the fire was 
reported, from 6am (16/12/95) to 6pm (17/12/95).   




Both (B)    















What were your main medical symptoms that you experience as a result of exposure to the 




Nature of symptoms 
Please indicate whether you have/had the following symptoms on a regular basis (almost 
every day). 
0 = No symptoms 
1 = Symptoms present 
2 = Symptoms present, Better 
3 = Symptoms present, No change 












1 year after 
the fire 
During 


































1 year after 
the fire 
During 




Burning skin  
     
Skin rash 
 




     
Watery eyes 
 
     
Blurred vision 
 




     
Decreased sense of 
smell 
     
Hoarse voice 
 
     
Burning, itchy, 
sore throat 




     
Cough 
 
     
Shortness of breath 
 
     
Tight chest 
 
     
Wheeze 
 
     
Phlegm in your 
chest 
     
Asthma 
 
     
Bronchitis 
 
     
Other lung 
problems 




























1 year after 
the fire 
During 





     
Difficulty 
remembering things 
     
Feeling 
downhearted or sad 
or depressed 
     
Anxious      
Having “nerves” 
troubles 





     
 








 2.3 Have you ever been treated for Tuberculosis?    ___ Yes  ___ No 
 
2.3.1 If Yes, when? (Year) _______ 
2.3.2 Have you completed you course of treatment? ___ Yes____No 
 







2.5 Smoking history:  ___Current smoker   ___ Ex-smoker   ___ Never 
 












         Yes No 
3.1 Have you had a child in the last 5 years? 
If Yes, answer the next questions: 
3.1.1 Did your child have a low birth weight?   
What was the weight? _________ grams 
3.1.2 Did your child have a birth defect?   
Please describe  
___________________________________________________________________________
______________________________________________________________ 















D. Health services used
Please provide the following information: 
1. Which health service providers (doctors, nurses, psychologists, clinics, hospitals, traditional
healers) have you consulted before 16 December 1995, and the reason for the consultations:
Date  Doctor/Hospital/Clinic     Reason 
Note: Append all medical certificates, special tests, reports to this page 
2. Which health service providers (doctors, nurses, psychologists, clinics, hospitals, traditional
healers) have you consulted after 16 December 1995, and the reason for the consultations:
Date  Doctor/Hospital/Clinic    Reason 
Note: Append all medical certificates, special tests, reports to this page 
3. If no health service providers (doctors, nurses, psychologists, clinics, hospitals, traditional
healers) were consulted after 16 December 1995 state the reason for not doing so?
___________________________________________________________________________
______________________________________________________________
4. Is there any other information you would like to share with us concerning your health
problems that may have resulted from exposures during the fire?
___________________________________________________________________________
______________________________________________________________
5. According to your opinion, which part of your body or organs have been affected or














 Claimant to undress to waist (shirt or top off) and remove shoes
0. Height  Weight 
1. General (pallour, cyanosis, wasting, etc.):
__________________________
2. Eyes:        _____
(note any conjunctival irritation, erosions, lacrimation, scarring, or  corneal scarring)
3. Eardrums: ___________ 
4. Nose: ______ 
(note the condition of mucosa, erosions, allergic characteristics)
5. Mouth and throat: _______ 
6. Skin:       _____________
(note any lesions and history of each, especially in relation to the sulphur fire)
7. CVS: ________ 
 Pulse  BP  Heart sounds 
8. Chest: __________ 
 Rate  Air entry Wheezes / Crackles _____ 
Peak flow__________ 
9. Abdomen: _______________ 
_______________ 
10. Mental state:  _________ __________ 














F. Overall medical assessment



























FOLLOW UP: Please include indication for referral 
Refer to Medical Reference Panel:              
Refer to General Practitioner Panel: 
Refer to Lawyer:  
Refer to Other Primary Healthcare Provider:  











Appendix 2: Medical Outcomes Study (SF-36) Questionnaire 
Please answer the following questions that relate to the quality of your health and life 
before and after the fire. 
Instructions: Please cross only one box.  For children, for any question where the word 
“work” appears, replace it with the word “school”. 
1. In general, would you say your health is:
  Excellent    Very Good           Good            Fair            Poor 
2. Compared to one year ago, how would you rate your health in general now? (Cross one)
Much better now than one year ago  
Somewhat better now than one year ago  
 About the same as one year ago 
 Somewhat worse now than one year ago 
 Much worse than one year ago 
3. Have you had any of the following problems with your work or other regular daily
activities as a result of your physical health.
 1 = Yes 
 2 = No 
Before 
the Fire 
At 1 month 
After the 
fire 






a. Cut down the amount of time 
you spent on work (school) or 
other activities. 
b. Accomplished less than you 
would like. 
c. Were limited in the kind of work 











d. Had difficulty performing the 
work (school) or other activities 
(e.g., it took extra effort). 
4. Have you had any of the following problems with your work or other regular daily
activities as a result of your emotional health (such as feeling depressed or anxious)?
 1 = Yes 
 2 = No 
Before 
the Fire 
At 1 month 
after the 
fire 




the past 4 
weeks 
a. Cut down the amount of time 
you spent on work (school) or 
other activities. 
b. Accomplished less than you 
would like. 
c. Were limited in the kind of work 
(school) or other activities. 
d. Had difficulty performing the 
work (school) or other activities 
(e.g., it took extra effort). 
5. Please answer the following questions according to the extent that you have experienced
the following:
1= Not at all 4= Quite a bit 




At 1 month 
after the 
fire 




the past 4 
weeks 
a. To what extent has your 
physical health or emotional 
problems interfered with your 
normal social activities with 
family, friends, partners 
neighbours, or groups? 












c. How much did bodily pain 
interfere with your normal work 
(including both work outside the 











6. These questions are about how you feel and how things have been with you since the time
of the fire.  For each question, please give the one answer that comes closest to the way
you have been feeling and for how much of the time: Please mark the appropriate box to
indicate the response.
1= All of the time 4= Some of the time 
2= Most of the time 5= A little of the time 











the past 4 
weeks 
a. Did you feel full of pep? 
b. Have you been a very nervous 
person? 
c. Have you felt so down in the 
dumps that nothing could cheer 
you up? 
d. Have you felt calm and peaceful? 
e. Did you have a lot of energy? 
f. Have you felt downhearted and 
blue? 
g. Did you feel worn out? 
h. Have you been a happy person? 
i. Did you feel tired? 
j. How much has your physical or 
emotional health interfered with 
your social activities (like visiting 












7. How TRUE or FALSE is each of the following statements for you?
1= Definitely True 4= Mostly False 
2= Mostly True 5= Definitely False 
3= Don’t Know 
Before the 
Fire 
At 1 month 
after the 
fire 






a. I seem to get sick a little easier 
than other people.  
b. I am as healthy as anybody I 
know. 
c. I expect my health to get worse. 
d. My health is excellent. 
8. The following items are about activities you might do during a typical day.  Does your
health now limit you in these activities?  If so, how much?  Please mark the appropriate
box to indicate the response.
YES, limited 
 a lot. 
YES, limited 
 a little. 
NO, not limited
 at all. 
a. Vigorous activities, such as running, 
lifting heavy objects, participating in 
strenuous sports.
1 2 3 
b. Moderate activities, such as moving 
a table, pushing a vacuum cleaner, 
riding a bicycle or working in the 
garden. 
1 2 3 
c. Lifting or carrying groceries. 1 2 3
d. Climbing several flights of stairs. 1 2 3
e. Climbing one flight of stairs. 1 2 3
f. Bending, kneeling, or stooping. 1 2 3
g. Walking more than a Km. 1 2 3
h. Walking several blocks. 1 2 3











Appendix 3: Patient Information Sheet 
Environmental And Host Factors Associated With Persistent Lower Respiratory Tract 
Symptoms Or Asthma Following Acute Environmental Exposure To Sulphur Dioxide 
(S02). 
Good Day,  
We are Roslynn Baatjies and Sister F Omar from the University of Cape Town medical school.  We 
are investigating the quality of life and respiratory health of residents in Macassar following the 
exposure to sulphur dioxide from the fire disaster in 1995.  The aim of the study is to investigate the 
environmental factors (exposure to sulphur dioxide) associated with persistent lower respiratory 
(chest) symptoms among residents acutely exposed to the sulphur vapours. We would be most 
grateful if you would consider participating in this study.  
Title of research project 
Environmental and host factors associated with persistent lower respiratory tract symptoms or 
asthma following acute environmental exposure to sulphur dioxide (s02).  
Description of the research project 
If you agree to participate you will be asked to complete the following tests: 
a) Complete a questionnaire.
An occupational health nurse, Sister F Omar, a member of our study team will interview you in
privacy to complete the questionnaire. You will be asked questions about any breathing or chest
problems, other medical questions, and where you were at the time of the fire.
b) Medical examination: An occupational health nurse, will perform a physical examination at the
Macassar clinic to determine your overall health status and the presence of any illness.  If you have
any respiratory problems you will be referred to a pulmonologist for further evaluation.
c) Lung function/Breathing tests
You will be asked to blow several times into a machine which measures how well your lungs are
working and detects whether you have asthma.
d) Confidentiality of information collected
Your name will not appear in any reports on this study. The records of questionnaires, examinations
and breathing tests will be kept completely confidential and will be seen only by members of the
study team.
e) Withdrawal from study
Your participation in this study is completely voluntary and you are free to withdraw from the study at











f) Risks and discomforts of the research
i) From the questionnaire and breathing tests
There are no risks from completing the questionnaire. There is a small chance that the initial breathing
test could cause you to become light-headed or faint. Having you complete the test in a seated
position under the observation of trained personnel greatly reduces the chance of your having such a
problem.
ii) From the examination
There are no risks from the examination.
g) Expected benefits to you and to others
You will be given a written copy of all your test results along with an explanation of what they mean, 
unless you tell us that you do not wish to receive this.  The results will be given to your legal 
representative as well, to process your claim for compensation for the health effects suffered as a 
result of the fire.  
h) Costs to you resulting from participation in the study
The study is offered at no cost to you.  
i)Contact person.
You may contact one of the following persons for answers to further questions about the research, 
your rights, or any injury you may feel is related to the study.   
University of Cape Town Researchers: 
Dr. Mohamed Jeebhay, Telephone No. (021) 406-6309 











Appendix 4: Consent Form 
Environmental And Host Factors Associated With Persistent Lower Respiratory Tract 
Symptoms Or Asthma Following Acute Environmental Exposure To Sulphur Dioxide 
(S02). 
STUDY NO. ______________ 
Consent of the participant 
I have read the information given above, or it has been read to me. I understand the meaning 
of this information, Dr./Mr./Ms. 
______________________________________________________ 
has offered to answer any questions concerning the study. By signing this form, I hereby 
consent to participate in the study.   
    Consent for medical release of documents 
I________________________________________ hereby consent to my legal representative, 
_________________________ and /or the medical team appointed by my legal 
representatives obtaining any medical records, reports or investigations pertaining to my 
medical history arising from the sulphur fire disaster in December 1995, from any doctor, 
hospital, clinic or other health professional. I also consent to any other medical information 
being released to the abovementioned that may be of relevance to my health problems prior to 
December 1995. 
Documentation of the consent 
One copy of this signed document will be kept together with our research    
records for this study. A copy of the information sheet about the study will be  
given to you to keep. 
I understand that I am free to withdraw from the study at any time without penalty. I also 
understand that the records of questionnaires, examinations and breathing tests will be kept 
completely confidential and will be seen only by members of the study team.  
 _______________________  _____________________________ 
Printed name of participant Signature, Mark, or Thumb Print         
_______________________  ______________________________ 
 Interviewer’s name (Print) Signature 











Appendix 5. Additional Tables 
Table 1. Demographic and health-related characteristics of Macassar residents stratified according to the presence  
   of persistent lower respiratory symptoms and/or asthma prior to and at 1 year and 6 years after the fire  
  (n=246) 
 PLRS and/or asthma  
 after the fire   
  No PLRS and/or asthma  
 after the fire 
Prior to fire 
 (n=24) 
  Year  1 
 (n=74)  
 Year 6  
 (n=74 )  
 Prior to fire 
 (n=222) 
  Year 1 
  (n=172) 
 Year 6 
( n=172) 
  N (%)    N (%)   N (%)    N (%)  N (%)   N (%) 
Demographic characteristics 
Age (years): 
Mean  ± SD 43 ± 13.1  44 ± 11.9 49 ± 11.9  41 ± 12.7   42 ± 13.0 47 ± 13.0 






Tuberculosis    
 10 (41.6) 
 11 (45.8) 
 3  (12.5) 
2 (8.3) 
  30 (40.5) 
  29 (39.1) 
  15 (20.2) 
  12 (16.2) 
  30 (40.5) 
  29 (39.1) 
  15 (20.2) 
  13 (17.5) 
  91 (40.9) 
  70 (31.5) 
  61 (27.4) 
  23(10.3) 
 71 (41.2) 
 52 (30.2) 
 49 (28.4) 
  16 (9.3) 
  71 (41.2) 
  52 (30.2) 
  49(28.4) 
  16 (9.3)  
Current treatment for  
asthma 
21(87.5)  45(60.8)   45(60.8)   0 (0)   0 (0)   0 (0) 
Other chronic diseases 
 Hypertension 3 (12.0)   12 (16.2)   17 (22.9)  25 (11.2)   36 (20.9)  44 (25.5) 
 Cardiac disease  2 (8.3)   3 (4.0)   8 (10.8)  4 (1.8)  8 (4.6)  11  (6.3) 
 Diabetes  2 (8.3)   11 (14.8)   10 (13.5)  7 (3.1)  9 (5.2)  12 (6.9) 
 Arthritis 1 (4.1)   5 (6.7)   3 (4.0)  21 (9.4)   27 (15.6)  22 (12.7) 
 Depression 0 (0.0)   4 (5.4)   8 (10.8)    10 (4.5)   12(6.9)  15 (8.7) 











Table 2.  Health- related quality of life SF-36 scale scores of Macassar residents prior to and  at 1 year and 6years 
after the fire (n=246) 
  Mean ± SD   Median (IQR) p-value
Role Physical 
Prior to fire   
Year 1   
Year 6 
  94 ± 23.0  
  66 ± 46.3 
  44 ± 48.3   
   100 (100-100)    
   100 (0-100) 
   0 (0-100) 
  <0.001     
Bodily Pain 
Prior to fire  
Year 1   
Year 6 
  92 ± 15.2  
  76 ± 26.7 
  64 ± 30.9   
   100 (78-100)   
   78 (55-100) 
   78 (33-100) 
  <0.001     
General Health 
Prior to fire  
Year 1   
Year 6 
  75 ± 18.1   
  39 ± 25.3   
  33 ± 24.8   
   81 (69-88)  
   31(19-56) 
   25(13-50) 
  <0.001     
Vitality 
Prior to fire 
Year 1 
Year 6 
  82 ± 18.1  
  61 ± 22.9  
  51 ± 20.6   
  85 (75-100)  
  60 (45-80) 
  50 (40-65) 
  <0.001     
Social Functioning 
Prior  to fire      
Year  1      
Year 6       
 88 ± 16.3 
 69 ± 25.5    
 60 ± 28.6    
  100 (80-100)     
  68 (48-80)   
  65 (43-80) 
  <0.001     
Role Emotional 
Prior  to fire   
Year 1 
Year 6 
 95± 21.5   
   72 ± 44.6 
   49 ± 49.3  
   100 (100-100)    
   100 (0-100) 
   50 (0-100) 
   <0.001    
Mental Health  
Prior to fire 
Year 1   
Year 6 
 82± 19.0  
 61± 22.9 
 51 ± 20.6    
 85 (75-100)    
 60 (45-80) 
 50 (40-65) 












Table 3. Health- related quality of life SF-36 scale scores of Macassar residents Sf-36  stratified according to the 
presence of persistenct lower respiratory symptoms and/or asthma prior to and at 1 year and at 6 years after the 
 fire (n=246) 
        PRIOR TO FIRE 
PLRS/asthma    ºPLRS/asthma   
(n=24)                   (n=222) 
        YEAR 1 
PLRS/asthma      ºPLRS/asthma 
(n=74)                     (n=172) 
       YEAR 6 
PLRS/asthma  ºPLRS/asthma 
(n=74)                 (n=172) 
Physical Functioning 
  Mean ± SD 
  Median (IQR) 
p-value
 N/D   N/D   N/D   N/D 24±25.1    39±28.5 
 15(0-35)  35(18-35) 
 <0.001 
Role Physical 
 Mean ± SD 
  Median (IQR)   
p-value
79 ± 41.4               96 ±19.6 
100 (100-100)      100 (100-100) 
0.004 
 55 ± 48.7   71 ± 44.6 
 100 (0-100)   100(0-100) 
 0.011 
33 ± 45.9    48 ± 48.7 
0(0-100)    0(0-100) 
0.024 
Bodily Pain 
 Mean ± SD 
 Median (IQR) 
p-value
86 ± 18.4   92 ± 14.8 
100(78-100)   100(78-100) 
0.070 
75 ± 27.5   77 ± 26.4 
78(55-100)   78(55-100) 
0.8456 
67 ± 30.8    67± 31.0 
78(33-100)   78(33-100) 
0.797 
General Health 
  Mean ± SD 
  Median (IQR) 
p-value
63 ± 21.1     76 ± 17.2 
81(69-88)      69 944-81) 
0.002 
24 ± 14.1   44 ± 26.1 
19 (13-31)  38 (25-69) 
< 0.001 
24 ± 17.8    37 ± 25.9 
19 (13-32)     32(13-56) 
< 0.001 
Vitality 
  Mean ± SD 
  Median (IQR) 
p-value
74 ± 19.4   83 ± 17.6 
85 (75-100)  75 (55-93) 
0.008 
58 ± 23.3    62 ± 21.9 
55 (40-80)    60 (45-78) 
0.148 
50 ± 20.1   52 ± 20.6 
50 (35-65)    50 (40-65) 
0.685 
Social Functioning 
 Mean ± SD 
 Median (IQR) 
p-value
83 ± 18.2   89 ± 16.0 
100(80-100)   84 (68-100) 
0.049 
65 ± 26.3   70 ± 25.1 
68(48-80)    68(51-100) 
0.149 
57 ± 28.8   62 ± 28.2 
55 (33-80)     43(68-80) 
0.239 
Role Emotional  
 Mean ± SD 
 Median (IQR) 
P-value
83 ± 38.0            96 ± 18.6 
100 (100-100)    100 (100-100) 
0.005 
68 ± 46.5   74 ± 43.8 
 100(0-100)    100(0-100) 
 0.330 
46 ± 49.2    51± 49.1 
0(0-100)   63(0-100) 
0.535 
Mental Health 
 Mean ± SD 
 Median (IQR) 
p- value
83 ± 18.7           83 ± 19.1 
88 (72-100)       90(70-100) 
0.926 
  69 ± 24.0    68 ± 24.2 
  72 (48-88)  70(52-90) 
  0.986 
62 ± 26.9   63 ± 24.9 
60(36-88)   60(44-84) 
0.8832  











Table 4. Health- related quality of life SF-36 scale scores of Macassar residents according to demographic and chronic diseases  
 characteristics at 6 year after the fire  (n= 246).  
 RP   BP   GH   PF   V   SF   RE  MH  
Age  
24 – 38  
39 – 46 
47 – 57 





























    50±27.8 
    48(28-73) 
    38±25.3 
    35(20-55) 
    24±24.8 
    15(5-40) 
    21±25.6 




















































   29±21.4 
   25(13-8) 
   40±28.4 
   31(13-3) 
   0.008 
    27±28.1 
    25(5-40) 
    48±32.4 
    45(20-78) 








































  32±22.5 
  25(13-44) 
  33±26.8 
  25(13-50) 
  34±25.0 
  28(13-56 
  0.932 
   37±28.1 
  35(15-55) 
  28±28.9 
  20(0-45) 
  38±27.3 
  35(15-53) 












































  13(13-31) 
  33±24.0 
  25(13-50) 
  0.120 
  31±28.4 
  30(0-55) 
  35±28.4 
  30(10-50) 















































































  32±23.7 
  25(13-38) 
  34±24.8 
  25(13-57) 
  0.784 
  26±26.6 
  15(0-40) 
  37±28.4 
  30(15-55) 

































  13±17.4 
  5(0-25) 






























  30(15-55) 















































































































  24±21.0 
  19(13-31) 
  34±24.7 
  31(13-50) 
  0.016 
  27±25.0 
  20(5-40) 
  35±28.5 
  30(10-50) 















































































  24±15.4 
  25(13-31) 
  34±25.4 
  31(13-56) 
  0.108 
  32±26.7 
  30(8-55) 
  35±28.6 
  30(10-50) 





















*Mann-Whitney test or **kruskal-Wallis test. Abrevation; RP – Role Physical, BP – Bodily Pain, GH – General Health,  V –










Table 5.  Mean difference in the health- related quality of life SF-36 scale scores of Macassar residents stratified according to the presence of persistent lower respiratory symptoms  
  and/or asthma 6 years after the fire (n=246) 
Mean  difference at year 1 
  Role Physical   Bodily Pain   General Health  
Mean (SD)  Median (IQR)  Mean (SD)   Median (IQR)  Mean (SD)    Median (IRR) 
PLRS/Asthma -36 ± 46.8   0(-100 – 0) -16 ± 23.9  0(-22.5 – 0) -50 ± 26.2 -56(-75 - -31)
No PLRS/Asthma -24 ± 42.9   0(-25 – 0) -14 ± 25.0   0(-22.5 – 0) -30 ± 30.3 -25 (-56 – 0)
p-value 0.036  0.383 <0.001
  Vitality   Social Functioning   Role Emotional         Mental Health 
Mean (SD)  Median (IQR) Mean (SD)  Median (IQR)  Mean (SD)   Median (IQR) Mean (SD)     Median (IQR) 
PLRS/Asthma -21 ±21.2 -17.5 (-35 – 0) -23 ± 24.4 - 20 (-40 – 0) -25 ±43.2   0(-50 – 0) -15 ± 19.4 - 12(-24 – 0
No PLRS/Asthma -21 ±22.2 -15 (-35 – 0) -18 ±24.1 -13 (-33 – 0) -22 ± 42.7   0 (0 – 0) -14 ± 18.3 -8 (-22 – 0)
p-value  0.931 0.114 0.583 0.403
Mean difference at year 6 
 Role Physical  Bodily Pain   General Health 
Mean (SD)  Median (IQR)  Mean (SD)   Median (IQR)  Mean (SD)    Median (IRR) 
PLRS/Asthma -58±47.9 -100 (-100 – 0 -24 ± 27.6 -18(-5 – 0) -50 ± 28.3 - 56 (-75 - - 25)
No PLRS/Asthma -46±48.6 -25 (-100 – 0) -24 ± 30.2 -15 (-45 – 0) -38 ± 30.3 -37 ( -63 - - 9)
p-value   0.098 0.983   0.004 
  Vitality   Social Functioning  Role Emotional      Mental Health 
Mean (SD)  Median (IQR) Mean (SD)  Median (IQR)  Mean (SD)   Median (IQR) Mean (SD)     Median (IQR) 
PLRS/Asthma -31 ± 23.3 -30(-50 - -15) -31 ± 28.0 - 28 (-58 – 0 -47 ± 49.3 0 (-100 – 0) -23 ± 19.1 -16 (-40 – 0
No PLRS/Asthma -29 ±23.1 -30 (-50 - -10) -27 ± 28.3 - 23 (-45 – 0) - 47 ± 49.2 0 (-100 – 0) -19±.19.5 -12(-34-0)












Table 6. Determinants of health -related quality of life according to SF-36 subscale Physical Functioning in the Macassar residents 6 
  years after the fire (n=246) : Univariate and multivariate linear regression models 





 - Previous vs. never 
 - Current  vs. never 
Previous Pulmonary Tuberculosis























 - 28.10 -  14.00
-1.18 – - 0.678
-17.16 – 0.59











 < 0.001 
























 -1.02 - -0.55
 -25.30 - -12.89
 -19.56 - -6.71
 -22.11 – 0.66
 77.12 – 101.25
  <0.001 
  <0.001 
  <0.001 
 0.065 
  <0.001 
Table 7. Determinants of health -related quality of life according to SF-36 subscale Role Physical in the Macassar residents 6 years  
  after the fire (n=246): Univariate and multivariate linear regression models 





 - Previous vs never 
 - Current vs never
 Current treatment for asthma























 -20.38 – 5.17
-1.24 - -0.31
 -16.51 – 11.96
 -15.27 – 15.23
 -31.69 – 0.063
-25.47 – 12.16
 -24.29 – 3.72
 -52.79 - -7.92
 -39.32 – 3.01
 -15.42 – 24.77
 -48.50 - -7.36
 -33.22 – 4.28
 -27.92 - -1.69
 -18.12 – 18.00
  0.242 
  0.001 
  0.754 
<0.001 
   0.051 
   0.487 
   0.149 
   0.008 
   0.093 
   0.647 
   0.008 
   0.130 
   0.027 











-46.39 –  -6.26
-25.85 – -0.34
 62.58 – 108.11 
   0.002 
   0.010 












Table 8. Determinants of health -related quality of life according to SF-36 subscale Bodily Pain in the Macassar residents 6 years  
  after the fire (n=246): Univariate and multivariate linear regression models 





 - Previous vs never 
 - Current vs never
Current treatment for asthma





































   0.048 
   0.003 
   0.892 
   0.948 
 <0.001 
   0.476 
   0.195 
   0.071 
   0.035 
   0.010 
   0.009 
 <0.001 
   0.831 











 < 0.001 
   0.002 
 <0.001 
Table 9. Determinants of health -related quality of life according to SF-36 subscale General Health in the Macassar residents 6 years  
   after the fire (n=246): Univariate and multivariate linear regression models 





 - Previous vs never 
 - Current vs never
Current treatment for asthma





































  0.001 
  0.152 
  0.725 
  0.567 
  0.002 
  0.374 
  0.644 
  0.150 
  0.346 
  0.141 
  0.012 
  0.031 
<0.001 















   0.002 












Table 10. Determinants of health -related quality of life according to SF-36 subscale Vitality in the Macassar residents 6 years after  
 the fire (n=246) : Univariate and multivariate linear regression models 





- Previous vs never 
 - Current vs never
Current treatment for asthma

























-10.98 –  1.01
-10.88– 1.98
-8.34 – 4.98









  0.067 
  0.019 
  0.103 
  0.174 
  0.62 
  0.711 
  0.046 
  0.531 
  0.200 
  0.633 
 <0.001 
   0.007 
   0.506 










 -22.81 – - 5.15
 -0.42 – - 0.03
 -15.35 – 0.58
54.78 – 74.01
  0.002 
  0.020 
  0.069 
 <0.001 
Table 11. Determinants of health -related quality of life according to SF-36 subscale Social Functioning in the Macassar residents 6  
 years after the fire (n=246) :Univariate and multivariate linear regression models 





 - Previous vs never 
 - Current vs never
Current treatment for asthma





































   0.295 
   0.088 
   0.845 
   0.917 
   0.333 
   0.874 
   0.626 
   0.074 
   0.286 
   0.687 
 <0.001 
   0.022 
   0.231 








  <0.001 











Table 12. Determinants of health -related quality of life according to SF-36 subscale Role Emotional in the Macassar residents 6  
 years after the fire (n=246):  Univariate and multivariate linear regression models 





 - Previous vs never 
 - Current vs never
Current treatment for asthma 





































    0.011 
    0.001 
    0.413 
    0.442 
    0.62 
    0.126 
    0.526 
    0.018 
    0.781 
    0.948 
    0.017 
    0.153 
    0.519 














    0.002 
    0.026 
    0.038 
    0.038 
Table 13. Determinants of health -related quality of life according to SF-36 subscale Mental Health in the Macassar residents 6  
 years after the fire (n=246) : Univariate and multivariate linear regression models 





 - Previous vs never 
 - Current vs never
Current treatment for asthma























 -18.30 - -5.18
 -0.34 – 0.15
 -12.06 – 2.68
-17.95 - -2.14
 -10.59 – 5.88










   0.464 
  0.212 
  0.013 
  0.574 
  0.667 
  0.197 
  0.802 
  0.429 
  0.438 
<0.001 
<0.001 
  0.958 






  Current vs never  















 71.08 – 83.77
<0.001 
< 0.001 
   0.003 
   0.010 
   0.008 












Table 14. Determinants of decline in health-related quality of life according to SF-36 subscales of Macassar residents at year 1 and year 6 after fire (n=246) in 
multivariate logistic regression models 
Each odds ratio is a separate model adjusted for age, gender, smoking, pulmonary TB, depression and Cardiac disease. *: p<0.05; **: p<0.01; ***: p<0.001 
RUDS – Reactive Upper Airways Dysfunction Syndrome. 
 Decline in SF – 36 scores after  1 year 
  ODDS RATIO (CI) 
  Decline in SF – 36 scores after  6 years   
 ODDS RATIO (CI)  
ROLE PHYSICAL   BODILY PAIN  GENERAL HEALTH  ROLE PHYSICAL  BODILY PAIN    GENERAL HEALTH   
Treatment for  
asthma   1.54 (0.77 – 3.05)   0.86  (0.43 – 1.72)   5.14 (1.76 – 15.05)**   1.19 (0.60 – 2.35)   0.95 (0.49 – 1.85)   3.65 (1.07 – 12.46)* 
Hypertension   0.50 (0.22 – 1.12)   0.86 (0.42 – 1.75)  0.50 (0.24- 1.04)   0.97 (0.49 – 1.90)  0.97 (0.50 – 1.87)   0.49 (0.21 – 1.13) 
Diabetes   2.64 (1.00 – 6.95)*   3.77 (1.39 – 10.17)**   4.66 (1.01 – 21.36)*   1.14 (0.43 – 2.97)   2.49 (0.90 – 6.86)  1.56 (0.41 – 5.81) 
Anxiety   0.75 (0.27 – 2.13)   3.07 (1.21 – 7.79)*  1.08 (0.39 – 2.96)   1.25 (0.52 – 3.02)   2.87 (1.12 – 7.32)*  1.14 (0.35 – 3.68) 
Arthritis   0.65 (0.27 – 1.57)   2.05 (0.94 – 4.44)  0.76 (0.34 – 1.71)   0.66 (0.27 -  1.58)   1.73 (0.71 – 4.22)  0.25 (0.09 – 0.64)** 
PLRS/asthma   1.97(1.09– 3.55)*   1.24 (0.70 – 2.21)  7.07 (2.88 – 17.35)***   1.57 (0.88 – 2.82)   1.05 (0.59 – 1.84)  3.50 (1.39 – 8.79)** 











Appendix 6: Data Capture Sheet 
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He . .. h·~I .. ed """,lltv of life _ ... Iden .. with .. tto .... followins; uposu .. to "';pl".d;oxIde 
Data Cap."", Shee t 
Date Cap'''''' No 
, , • 
1. 'ium~me 
2. F; ~. nMne/> 
l . Add",,, t t 
4 . Gende, ~eh) 
Fern"e 1 2) 
S. O No 
6. ~ofb<fth ~Month ". -' -
1. Aie at . ime of di ~.e, 
8. u,,,.,1 Of expos",e at the time of fi", ~ h ) 
High i 2) ,. , 
1. 'imoki", t>e_i ..... , Ne ve,h) 
Ell.smokr ( 12) 
C"""n' """ke, i 3) 
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1.0. T..,;otmen. (Proxy fOf o."",;c 01",_<) 
l b . T", .. m e nt fOf ",th,.,. "." ( 1) 
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2. Oin; c Attend...-.cr (Prn>:y fOf Chronic Oi..,~..,.) 
~e befo", fife 
DoctOffHo<J>i ... I/aini< bef"", fife 
1Ie~50n bef"", fife 
Date me,fi fe 
IloctOf/HD<pit.ol/ O in ic me, fife 















Before fire (1) (2) 21
1 year (1) (2) 22
6 years (1) (2) 23
3b. Difficulty remembering things YES NO
Before fire (1) (2) 24
1 year (1) (2) 25
6 years (1) (2) 26
3c. Feeling sad & depressed YES NO
Before fire (1) (2) 27
1 year (1) (2) 28
6 years (1) (2) 29
3d. Anxious YES NO
Before fire (1) (2) 30
1 year (1) (2) 31
6 years (1) (2) 32
3e. Having "nerves" troubles YES NO
Before fire (1) (2) 33
1 year (1) (2) 34
6 years (1) (2) 35
3f. Other symptoms YES NO
Before fire (1) (2) 36
1 year (1) (2) 37





Asthma (1) (2) 39
Bronchitis (1) (2) 40
TB (1) (2) 41
Hypertension (1) (2) 42
Diabetic (1) (2) 43
Depression (1) (2) 44
anxiety (1) (2) 45
Cardiac Hx (1) (2) 46
Muscularskel (1) (2) 47
4b. Chronic diseases at 1 year
YES NO
Asthma (1) (2) 48
Bronchitis (1) (2) 49
TB (1) (2) 50
Hypertension (1) (2) 51
Diabetic (1) (2) 52
depression (1) (2) 53











Cardiac Hx (1) (2) 55
Muscularskel (1) (2) 56
4c. Chronic diseases at 6 years
YES NO
Asthma (1) (2) 57
Bronchitis (1) (2) 58
TB (1) (2) 59
Hypertension (1) (2) 60
Diabetic (1) (2) 61
Depression (1) (2) 62
anxiety (1) (2) 63
Cardiac Hx (1) (2) 64
Muscularskel (1) (2) 65
D. BASED ON FINAL DIAGNOSIS BY SPECIALIST
1. RADS yes (1) 66
No (2)
2. Asthma aggravation Yes (1) 67
No (2)
3. COPD Yes (1) 68
No (2)
4. Pulm TB Yes (1) 69
No (2)
5. Rhinitis aggravation Yes (1) 70
No (2)
6. RUDS Yes (1) 71
No (2)































1 year (1) (2) 77
6 years (1) (2) 78
YES NO
3b. Accomplished less Before fire (1) (2) 79
1 year (1) (2) 80
6 years (1) (2) 81
YES NO
3c. Limited in work or other activities Before fire (1) (2) 82
1 year (1) (2) 83
6 years (1) (2) 84
YES NO
3d. Difficulty work and other activities Before fire (1) (2) 85
1 year (1) (2) 86
6 years (1) (2) 87
4. ROLE ‐ EMOTIONAL (RE)
YES NO
4a. Time reduced Before fire (1) (2) 88
1 year (1) (2) 89
6 years (1) (2) 90
YES NO
4b. Accomplished less Before fire (1) (2) 91
1 year (1) (2) 92
6 years (1) (2) 93
YES NO
4c. Limited in work or other activities Before fire (1) (2) 94
1 year (1) (2) 95
6 years (1) (2) 96
YES NO 97
4d. Difficulty work and other activities Before fire (1) (2) 98













5a. Phys/emotional health  Before fire (1) (2) (3) (4) (5) 100
  [(SF) social ‐extent] 1 year (1) (2) (3) (4) (5) 101











5b. Bodily pain Before fire (1) (2) (3) (4) (5) 103
 (BP) 1 year (1) (2) (3) (4) (5) 104











5c. Bodily pain interference Before fire (1) (2) (3) (4) (5) 106
  (BP) 1 year (1) (2) (3) (4) (5) 107

























6a.  Level of Pep  Before fire (1) (2) (3) (4) (5) (6) 109
  (V) 1 year (1) (2) (3) (4) (5) (6) 110














6b.  Level Nervous  Before fire (1) (2) (3) (4) (5) (6) 112
    (MH) 1 year (1) (2) (3) (4) (5) (6) 113














6c.  Level of Mood Before fire (1) (2) (3) (4) (5) (6) 115
  (MH) 1 year (1) (2) (3) (4) (5) (6) 116














6d.  Level calm/peaceBefore fire (1) (2) (3) (4) (5) (6) 118
  (MH) 1 year (1) (2) (3) (4) (5) (6) 119














6e.  Lot of  Energy Before fire (1) (2) (3) (4) (5) (6) 121
  (V) 1 year (1) (2) (3) (4) (5) (6) 122














6f.  Level down/blue Before fire (1) (2) (3) (4) (5) (6) 124
    (MH) 1 year (1) (2) (3) (4) (5) (6) 125














6g.  Level worn‐out Before fire (1) (2) (3) (4) (5) (6) 127
   (V) 1 year (1) (2) (3) (4) (5) (6) 128














6h. Level happiness Before fire (1) (2) (3) (4) (5) (6) 130
  (MH)  1 year (1) (2) (3) (4) (5) (6) 131
























6i.  Tiredness Before fire (1) (2) (3) (4) (5) (6) 133
  (V) 1 year (1) (2) (3) (4) (5) (6) 134














6j. Social activity Before fire (1) (2) (3) (4) (5) (6) 136
  (SF) 1 year (1) (2) (3) (4) (5) (6) 137












7a. Sicker than other peopleBefore fire (1) (2) (3) (4) (5) 139
1 year (1) (2) (3) (4) (5) 140












Before fire (1) (2) (3) (4) (5) 142
1 year (1) (2) (3) (4) (5) 143












Before fire (1) (2) (3) (4) (5) 145
1 year (1) (2) (3) (4) (5) 146












Before fire (1) (2) (3) (4) (5) 148
1 year (1) (2) (3) (4) (5) 149
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Appendix 8: Quality Of Life Research Journal - Instructions For Authors. 
Quality of Life Research 
Article types 
Quality of Life Research welcomes scientific articles in the following categories:  
• Full-Length Original Articles (must include a structured abstract, maximum word limit of
4,000 words exclusive of abstract, tables, figures, and references)
• Brief Communications (maximum word limit of 1,500 words, exclusive of abstract, tables,
figures, and references). See section below on Brief Communications.
Brief Communications
Brief communications are a maximum of 1,500 words, exclusive of abstract, figures, tables
and references. Any topic can be submitted as a brief communication, but all manuscripts that
report cross-cultural adaptations of existing measures will only be considered for publication
as brief communications in Quality of Life Research. If a paper of this type provides
substantially new methodological and/or substantive knowledge (e.g., a superior method of
cross cultural adaptation, more thorough evaluation of the original instrument being adapted,
multi language or multi country comparisons, etc.), authors should include a letter with their
submission justifying the need for a full length report.
Language 
We appreciate any efforts that you make to ensure that the language is corrected before 
submission. This will greatly improve the legibility of your paper if English is not your first 
language. 
Ethical standards 
Manuscripts submitted for publication must contain a statement to the effect that all human 
studies have been approved by the appropriate ethics committee (including the approval 
number) and have therefore been performed in accordance with the ethical standards laid 
down in the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all 
persons gave their informed consent prior to their inclusion in the study. Details that might 
disclose the identity of the subjects under study should be omitted.  
The editors reserve the right to reject manuscripts that do not comply with the above-
mentioned requirements. The author will be held responsible for false statements or failure to 
satisfy the above-mentioned requirements. 
Manuscript submission 
Legal requirements 
Submission of a manuscript implies: that the work described has not been published before; 
that it is not under consideration for publication anywhere else; that its publication has been 
approved by all co-authors, if any, as well as by the responsible authorities – tacitly or 
explicitly – at the institute where the work has been carried out. The publisher will not be 












Authors wishing to include figures, tables, or text passages that have already been published 
elsewhere are required to obtain permission from the copyright owner(s) and to include 
evidence that such permission has been granted when submitting their papers. Any material 
received without such evidence will be assumed to originate from the authors. 
How to submit 
Authors should submit their manuscripts online. Electronic submission substantially reduces 
the editorial processing and reviewing times and shortens overall publication times. Please 
connect directly to the site and upload all of your manuscript files following the instructions 




The title page should include: 
- A concise and informative title
- The name(s) of the author(s)
- The affiliation(s) and address(es) of the author(s)
- The e-mail address, telephone and fax numbers of the corresponding author
- The number of words in the manuscript excluding the abstract, tables, figures, and
references.
Abstract 
Please provide a structured abstract of no more than 200 words which should be divided into 
the following sections: 





Please provide 4 to 6 keywords which can be used for indexing purposes. Use terms from the 
Medical Subject Headings list from Index Medicus. 
Abbreviations 
Abbreviations and their explanations should be collected in a list. 
Text 
Text formatting 
For submission in Word 
• Use a normal, plain font (e.g., 12-point Times Roman) for text.
• Use italics for emphasis.
• Use the automatic page and line numbering functions.
• Do not use field functions.
• Use tab stops or other commands for indents, not the space bar.
• Use the table function, not spreadsheets, to make tables.











Note: If you use Word 2007, do not create the equations with the default equation editor but 
use MathType instead. 
• Save your file in either of the two formats doc and rtf. Do not submit docx files.
 Word template
Heading levels 
Please use no more than three levels of displayed headings. 
SI units 
Please always use internationally accepted signs and symbols for units, SI units. 
Terminology 
Generic names of drugs are preferred; if trade names are used, the generic name should be 
given at first mention. 
Equations 
Please use the standard mathematical notation for formulae, symbols etc.: 
• Italic for single letters that denote mathematical constants, variables, and unknown
quantities
• Roman/upright for numerals, operators, and punctuation, and commonly defined functions
or abbreviations, e.g., cos, det, e or exp, lim, log, max, min, sin, tan, d (for derivative)
• Bold for vectors, tensors, and matrices.
Footnotes 
Do not use footnotes (except for acknowledgement footnote on the title page). 
Acknowledgments 
Acknowledgments of people, grants, funds, etc. can be placed in a separate section before the 
reference list. The names of funding organizations should be written in full. 
References 
The list of References should only include works that are cited in the text and that have been 
published or accepted for publication. Personal communications and unpublished works 
should only be mentioned in the text. Do not use footnotes or endnotes as a substitute for a 
reference list. 
Citation in text 
Citations in the text should be identified by numbers in square brackets. The numbers should 
be given in the order of appearance of the citations in the text. Some examples: 
• Health-related quality of life research spans many disciplines [3].
• This result was later contradicted by Becker and Seligman [9].
• This effect has been widely studied [1-3, 7].
List style 
Reference list entries should be numbered consecutively in the order cited 
Journal article 
1. Harris, M., Karper, E., Stacks, G., Hoffman, D., DeNiro, R., Cruz, P., et al. (2001). Writing
labs and the Hollywood connection. Journal of Film Writing, 44(3), 213–245.
Article by DOI
2. Slifka, M.K., Whitton, J.L. (2000) Clinical implications of dysregulated cytokine












3. Calfee, R. C., & Valencia, R. R. (1991). APA guide to preparing manuscripts for journal
publication. Washington, DC: American Psychological Association.
Book chapter
4. O’Neil, J. M., & Egan, J. (1992). Men’s and women’s gender role journeys: Metaphor for
healing, transition, and transformation. In B. R. Wainrib (Ed.), Gender issues across the life
cycle (pp. 107–123). New York: Springer.
Online document
5. Abou-Allaban, Y., Dell, M. L., Greenberg, W., Lomax, J., Peteet, J., Torres, M., Cowell,
V. (2006). Religious/spiritual commitments and psychiatric practice. Resource document.
American Psychiatric Association. http://www.psych.org/edu/other_res/lib_archives/archives/
200604.pdf. Accessed 25 June 2007.
Tables 
• All tables are to be numbered using Arabic numerals.
• Tables should always be cited in text in consecutive numerical order.
• For each table, please supply a table heading. The table title should explain clearly and
concisely the components of the table.
• Identify any previously published material by giving the original source in the form of a
reference at the end of the table heading.
Footnotes to tables should be indicated by superscript lower-case letters (or asterisks for
significance values and other statistical data) and included beneath the table body.
Figures
• All figures are to be numbered using Arabic numerals.
• Figure parts should be denoted by lowercase letters.
• Figures should always be cited in text in consecutive numerical order.
• For each figure, please supply a figure caption.
• Make sure to identify all elements found in the figure in the caption.
• Identify any previously published material by giving the original source in the form of a
reference at the end of the caption.




If Electronic supplementary material (ESM) is submitted, it will be published as received 
from the author in the online version only.  
ESM may consist of 
• information that cannot be printed: animations, video clips, sound recordings
• information that is more convenient in electronic form: sequences, spectral data, etc.
• large original data, e.g. additional tables, illustrations, etc.
• If supplying any ESM, the text must make specific mention of the material as a citation,
similar to that of figures and tables (e.g., “. . . as shown in Animation 3.”).
For details on formats and other information, please follow the hyperlink to the specific























Upon acceptance of your article you will receive a link to the special Springer web page with 
questions related to: 
Open Choice 
In addition to the normal publication process (whereby an article is submitted to the journal 
and access to that article is granted to customers who have purchased a subscription), 
Springer now provides an alternative publishing option: Springer Open Choice. A Springer 
Open Choice article receives all the benefits of a regular subscription-based article, but in 
addition is made available publicly through Springer’s online platform SpringerLink. We 
regret that Springer Open Choice cannot be ordered for published articles.  
 Springer Open Choice
Copyright 
Copyright transfer Authors will be asked to transfer copyright of the article to the Publisher 
(or grant the Publisher exclusive publication and dissemination rights). This will ensure the 
widest possible protection and dissemination of information under copyright laws. 
Open Choice articles do not require transfer of copyright as the copyright remains with the 
author. In opting for open access, they agree to the Springer Open Choice Licence. 
Offprints/Reprints 
Free and/or additional offprints can be ordered by the corresponding author. Twenty-five 
offprints of each contribution are supplied free of charge to the corresponding author. 
Color in print 
Online publication of color illustrations is free of charge. For color in the print version, 
authors will be expected to make a contribution towards the extra costs. 
Proof reading 
The purpose of the proof is to check for typesetting errors and the completeness and accuracy 
of the text, tables and figures. Substantial changes in content, e.g., new results, corrected 
values, title and authorship, are not allowed without the approval of the Editor. 
After online publication, further changes can only be made in the form of an Erratum, which 
will be hyperlinked to the article. 
Online first 
The article will be published online after receipt of the corrected proofs. This is the official 
first publication citable with the DOI. After release of the printed version, the paper can also 
be cited by issue and page numbers. 
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